HTTP 200 OK
Allow: GET, POST, HEAD, OPTIONS
Content-Type: application/json
Vary: Accept
{
"recordsFiltered": 47012,
"recordsTotal": 47012,
"next": "http://fdaaa.trialstracker.net/api/trials/?format=api&length=300&ordering=registry_id&start=46500",
"previous": "http://fdaaa.trialstracker.net/api/trials/?format=api&length=300&ordering=registry_id&start=45900",
"results": [
{
"registry_id": "NCT06117774",
"publication_url": "https://clinicaltrials.gov/study/NCT06117774",
"title": "A Phase 3, Randomized, Double-blind, Placebo-controlled, Multicenter Study of Tarlatamab Therapy in Subjects With Limited-Stage Small-Cell Lung Cancer (LS-SCLC) Who Have Not Progressed Following Concurrent Chemoradiation Therapy",
"has_exemption": false,
"start_date": "2024-02-20",
"completion_date": "2030-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Amgen",
"sponsor_slug": "amgen",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06013865",
"publication_url": "https://clinicaltrials.gov/study/NCT06013865",
"title": "An Exploratory Investigation of the Safety of Empagliflozin in Kidney Transplant Recipients (SEKTR)",
"has_exemption": false,
"start_date": "2024-04-05",
"completion_date": "2030-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "VA Office of Research and Development",
"sponsor_slug": "va-office-of-research-and-development",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06424756",
"publication_url": "https://clinicaltrials.gov/study/NCT06424756",
"title": "Role of Mitochondria-derived Oxidative Stress on Microvascular Endothelial Function in Healthy Non-Hispanic Black and White Adults",
"has_exemption": false,
"start_date": "2024-07-01",
"completion_date": "2030-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Georgia",
"sponsor_slug": "university-of-georgia",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06802315",
"publication_url": "https://clinicaltrials.gov/study/NCT06802315",
"title": "A Phase II Study of Intensity Modulated Total Marrow Irradiation (IM-TMI) in Addition to Myeloablative Fludarabine/Busulfan and Post-Transplant Cyclophosphamide (PTCY) for Fully Human Leukocyte Antigen (HLA)-Matched and Partially-HLA Mismatched Allogeneic Transplantation Patients With High-Risk AML, CML, and MDS",
"has_exemption": false,
"start_date": "2025-02-04",
"completion_date": "2030-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Illinois at Chicago",
"sponsor_slug": "university-of-illinois-at-chicago",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06322576",
"publication_url": "https://clinicaltrials.gov/study/NCT06322576",
"title": "A Phase 2, Single-Arm, Multi-center Study of 177Lu-PSMA (177Lu-PNT2002) in Patients With PSMA-Positive Adenoid Cystic Carcinoma",
"has_exemption": false,
"start_date": "2025-02-10",
"completion_date": "2030-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins",
"sponsor_slug": "sidney-kimmel-comprehensive-cancer-center-at-johns-hopkins",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06926790",
"publication_url": "https://clinicaltrials.gov/study/NCT06926790",
"title": "Neoadjuvant Nivolumab Plus Ipilimumab in Resectable Non-small Cell Lung Cancer",
"has_exemption": false,
"start_date": "2025-02-17",
"completion_date": "2030-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "The First Affiliated Hospital of Guangzhou Medical University",
"sponsor_slug": "the-first-affiliated-hospital-of-guangzhou-medical-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06805305",
"publication_url": "https://clinicaltrials.gov/study/NCT06805305",
"title": "Randomized Study of DOC1021 Dendritic Cell Immunotherapy in Combination With Standard of Care for Newly Diagnosed Adult Glioblastoma",
"has_exemption": false,
"start_date": "2025-03-17",
"completion_date": "2030-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Diakonos Oncology Corporation",
"sponsor_slug": "diakonos-oncology-corporation",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06847269",
"publication_url": "https://clinicaltrials.gov/study/NCT06847269",
"title": "CAR T CELL Therapy for Pediatric, Adolescent and Young Adult Patients With CD19-Positive Leukemia: An Investigation of Lymphodepleting Chemotherapy Pharmacokinetics",
"has_exemption": false,
"start_date": "2025-05-21",
"completion_date": "2030-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "St. Jude Children's Research Hospital",
"sponsor_slug": "st-jude-childrens-research-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04387305",
"publication_url": "https://clinicaltrials.gov/study/NCT04387305",
"title": "Traumatic Injury Clinical Trial Evaluating Tranexamic Acid in Children (TIC-TOC): an Efficacy Study",
"has_exemption": false,
"start_date": "2025-10-01",
"completion_date": "2030-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Daniel Nishijima, MD, MAS",
"sponsor_slug": "daniel-nishijima-md-mas",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07193511",
"publication_url": "https://clinicaltrials.gov/study/NCT07193511",
"title": "A Phase 1/2, First-in-Human Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity of AVZO-103, a Nectin4/Trop2 ADC, as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Urothelial Cancer or Other Solid Tumors",
"has_exemption": false,
"start_date": "2025-10-02",
"completion_date": "2030-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Avenzo Therapeutics, Inc.",
"sponsor_slug": "avenzo-therapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06937866",
"publication_url": "https://clinicaltrials.gov/study/NCT06937866",
"title": "Maintenance Zanzalintinib With Oral Etoposide Following High-dose Chemotherapy in Patients With Relapsed Metastatic Germ-cell Tumor",
"has_exemption": false,
"start_date": "2025-11-12",
"completion_date": "2030-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Indiana University",
"sponsor_slug": "indiana-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07108270",
"publication_url": "https://clinicaltrials.gov/study/NCT07108270",
"title": "A Phase 2, Multicenter, Open-label, Single Arm Study of Dostarlimab Plus Carboplatin-paclitaxel Followed by Dostarlimab Monotherapy in Participants With dMMR/MSI-H Primary Advanced or Recurrent Endometrial Cancer in China (China RUBY)",
"has_exemption": false,
"start_date": "2025-11-30",
"completion_date": "2030-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "GlaxoSmithKline",
"sponsor_slug": "glaxosmithkline",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07159841",
"publication_url": "https://clinicaltrials.gov/study/NCT07159841",
"title": "A Phase 2/3 Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Atumelnant Treatment in Pediatric Participants With Congenital Adrenal Hyperplasia Including a Long-Term Extension",
"has_exemption": false,
"start_date": "2025-11-30",
"completion_date": "2030-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Crinetics Pharmaceuticals Inc.",
"sponsor_slug": "crinetics-pharmaceuticals-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07187466",
"publication_url": "https://clinicaltrials.gov/study/NCT07187466",
"title": "Sequential Multiple Assignment Randomized Trial to Treat Urinary Symptoms in Parkinson Disease",
"has_exemption": false,
"start_date": "2026-01-01",
"completion_date": "2030-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "VA Office of Research and Development",
"sponsor_slug": "va-office-of-research-and-development",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07158242",
"publication_url": "https://clinicaltrials.gov/study/NCT07158242",
"title": "A Phase III Randomized Double-Blind Multi-Center Treat-Through Study to Evaluate the Pharmacokinetics, Safety and Efficacy of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Children Aged 2 - 17 Years With Moderately to Severely Active Ulcerative Colitis",
"has_exemption": false,
"start_date": "2026-03-31",
"completion_date": "2030-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Hoffmann-La Roche",
"sponsor_slug": "hoffmann-la-roche",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07262060",
"publication_url": "https://clinicaltrials.gov/study/NCT07262060",
"title": "Optimizing Caffeine Therapy for Hypoxia in Preterm Neonates: A Randomized Trial Assessing Efficacy, Acute Kidney and Brain Injury, Safety, and Pharmacokinetics",
"has_exemption": false,
"start_date": "2026-03-31",
"completion_date": "2030-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Wisconsin, Madison",
"sponsor_slug": "university-of-wisconsin-madison",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06881823",
"publication_url": "https://clinicaltrials.gov/study/NCT06881823",
"title": "NeoPSMA: A Phase I/II, Open-label, Multi-center Study of Neoadjuvant Treatment With [177Lu]Lu-PSMA-R2 (AAA602) and [225Ac]Ac-PSMA-R2 (AAA802) in Adults With Prostate-specific Membrane Antigen (PSMA) Positive High-risk Localized Prostate Cancer (HRLPC) Prior to Radical Prostatectomy and Pelvic Lymph Node Dissection",
"has_exemption": false,
"start_date": "2026-06-29",
"completion_date": "2030-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04042402",
"publication_url": "https://clinicaltrials.gov/study/NCT04042402",
"title": "An Open-Label Roll-Over Study to Evaluate the Long-Term Safety and Efficacy of DCR-PHXC Solution for Injection (Subcutaneous Use) in Patients With Primary Hyperoxaluria",
"has_exemption": false,
"start_date": "2019-07-09",
"completion_date": "2030-04-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Dicerna Pharmaceuticals, Inc., a Novo Nordisk company",
"sponsor_slug": "dicerna-pharmaceuticals-inc-a-novo-nordisk-company",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07112287",
"publication_url": "https://clinicaltrials.gov/study/NCT07112287",
"title": "MyeloGen: Germline Testing for Predisposition to Myeloid Malignancies",
"has_exemption": false,
"start_date": "2026-02-28",
"completion_date": "2030-04-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Christopher Reilly",
"sponsor_slug": "christopher-reilly",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07029776",
"publication_url": "https://clinicaltrials.gov/study/NCT07029776",
"title": "A Phase 2 Study Exploring the Use of Bispecific Antibodies to Improve Progression Free Survival in Patients With High-Risk Newly Diagnosed Multiple Myeloma (MMulti-Immune HR)",
"has_exemption": false,
"start_date": "2026-04-01",
"completion_date": "2030-04-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Arkansas",
"sponsor_slug": "university-of-arkansas",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05972629",
"publication_url": "https://clinicaltrials.gov/study/NCT05972629",
"title": "A Phase 1/Phase 2, Open-label, Dose-escalation, and Dose Expansion Study to Evaluate the Safety, Tolerability, and Efficacy of SAR444836, an Adeno-associated Viral Vector-mediated Gene Transfer of Human Phenylalanine Hydroxylase, in Adult Participants With Phenylketonuria",
"has_exemption": false,
"start_date": "2023-08-07",
"completion_date": "2030-04-02",
"has_results": false,
"results_due": false,
"sponsor_name": "Sanofi",
"sponsor_slug": "sanofi",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07146906",
"publication_url": "https://clinicaltrials.gov/study/NCT07146906",
"title": "An Open-label, Multicenter Study to Assess the Effect of Zigakibart Treatment on Histologic, Circulating, and Excreted Markers of Kidney Disease and Dysfunction in Adult Patients With IgA Nephropathy.",
"has_exemption": false,
"start_date": "2025-11-18",
"completion_date": "2030-04-09",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03718403",
"publication_url": "https://clinicaltrials.gov/study/NCT03718403",
"title": "Effect of Theophylline in Pseudohypoparathyroidism",
"has_exemption": false,
"start_date": "2019-11-11",
"completion_date": "2030-04-10",
"has_results": false,
"results_due": false,
"sponsor_name": "Massachusetts General Hospital",
"sponsor_slug": "massachusetts-general-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05582993",
"publication_url": "https://clinicaltrials.gov/study/NCT05582993",
"title": "A Phase 3, Prospective, Open-label, Uncontrolled, Multicenter Study on Efficacy and Safety of Prophylaxis With Vonicog Alfa (rVWF) in Children Diagnosed With Severe Von Willebrand Disease",
"has_exemption": false,
"start_date": "2024-11-06",
"completion_date": "2030-04-11",
"has_results": false,
"results_due": false,
"sponsor_name": "Takeda",
"sponsor_slug": "takeda",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06632977",
"publication_url": "https://clinicaltrials.gov/study/NCT06632977",
"title": "PREcision DIagnostics in Prostate Cancer Treatment (PREDICT)",
"has_exemption": false,
"start_date": "2025-02-06",
"completion_date": "2030-04-11",
"has_results": false,
"results_due": false,
"sponsor_name": "Alliance for Clinical Trials in Oncology",
"sponsor_slug": "alliance-for-clinical-trials-in-oncology",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07061574",
"publication_url": "https://clinicaltrials.gov/study/NCT07061574",
"title": "A Randomized Phase 1/2 Trial of Low Dose Anti-thymocyte Globulin (ATG) With Subsequent Adalimumab or Verapamil in New Onset Type 1 Diabetes",
"has_exemption": false,
"start_date": "2026-12-15",
"completion_date": "2030-04-15",
"has_results": false,
"results_due": false,
"sponsor_name": "City of Hope Medical Center",
"sponsor_slug": "city-of-hope-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06397703",
"publication_url": "https://clinicaltrials.gov/study/NCT06397703",
"title": "A Phase II Prospective 2-Arm Cohort Interventional Trial Utilizing Ultra-Hypofractionated SBRT With or Without Short Course Androgen Deprivation Therapy For Unfavorable Intermediate Risk Prostate Cancer",
"has_exemption": false,
"start_date": "2024-04-16",
"completion_date": "2030-04-16",
"has_results": false,
"results_due": false,
"sponsor_name": "NYU Langone Health",
"sponsor_slug": "nyu-langone-health",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06686394",
"publication_url": "https://clinicaltrials.gov/study/NCT06686394",
"title": "HERTHENA-Breast-01: A Phase 1b/2, Multicenter, Open-label, Dose-Finding Study to Evaluate the Safety and Antitumor Activity of Patritumab Deruxtecan in Participants With HER2 Positive Unresectable Locally Advanced Breast Cancer or Metastatic Breast Cancer",
"has_exemption": false,
"start_date": "2025-02-26",
"completion_date": "2030-04-18",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06133972",
"publication_url": "https://clinicaltrials.gov/study/NCT06133972",
"title": "A Randomized, Double-blind, Placebo-controlled Extension Study to Assess the Long-term Safety and Tolerability of Ianalumab in Patients With Systemic Lupus Erythematosus (SIRIUS-SLE Extension)",
"has_exemption": false,
"start_date": "2024-05-21",
"completion_date": "2030-04-19",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07153497",
"publication_url": "https://clinicaltrials.gov/study/NCT07153497",
"title": "A Randomized Phase 2 Trial of Olutasidenib-Based Therapies in Patients With Newly Diagnosed IDH1-Mutant Myeloid Malignancies: A MyeloMATCH Substudy",
"has_exemption": false,
"start_date": "2026-02-26",
"completion_date": "2030-04-26",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04408625",
"publication_url": "https://clinicaltrials.gov/study/NCT04408625",
"title": "A Phase 1/2 Ascending Dose Study to Evaluate the Safety and Effects on Progranulin Levels of LY3884963 in Patients With Fronto-Temporal Dementia With Progranulin Mutations (FTD-GRN)",
"has_exemption": false,
"start_date": "2020-11-09",
"completion_date": "2030-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Prevail Therapeutics",
"sponsor_slug": "prevail-therapeutics",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04806854",
"publication_url": "https://clinicaltrials.gov/study/NCT04806854",
"title": "A Single-Center, Randomized, Open-Label, Parallel Arm Study of Daily Oral LUM-201 in Naive-to-Treatment, Prepubertal Children With Idiopathic Pediatric Growth Hormone Deficiency (PGHD)",
"has_exemption": false,
"start_date": "2021-07-14",
"completion_date": "2030-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Lumos Pharma",
"sponsor_slug": "lumos-pharma",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05919108",
"publication_url": "https://clinicaltrials.gov/study/NCT05919108",
"title": "Neoadjuvant Neratinib in Stage I-III HER2-Mutated Lobular Breast Cancers",
"has_exemption": false,
"start_date": "2024-05-30",
"completion_date": "2030-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Vanderbilt-Ingram Cancer Center",
"sponsor_slug": "vanderbilt-ingram-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06322108",
"publication_url": "https://clinicaltrials.gov/study/NCT06322108",
"title": "Assessment of the Safety and Efficacy of Balstilimab in Combination With Botensilimab for the Treatment of Non-Small Cell Lung Cancer (IMMONC0008)",
"has_exemption": false,
"start_date": "2024-06-13",
"completion_date": "2030-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Immune Oncology Research Institute",
"sponsor_slug": "immune-oncology-research-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05829460",
"publication_url": "https://clinicaltrials.gov/study/NCT05829460",
"title": "Primary Prevention and Uterine Preservation in Premenopausal Women With Obesity and Endometrial Hyperplasia",
"has_exemption": false,
"start_date": "2025-03-12",
"completion_date": "2030-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Washington University School of Medicine",
"sponsor_slug": "washington-university-school-of-medicine",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06721689",
"publication_url": "https://clinicaltrials.gov/study/NCT06721689",
"title": "A Phase 1/2 Clinical Trial of the Novel Topoisomerase I Inhibitor PEEL-224 as a Single Agent and in Combination With Vincristine and Temozolomide in Children With Refractory, Progressive or Relapsed Solid Tumors",
"has_exemption": false,
"start_date": "2025-03-23",
"completion_date": "2030-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Theodore Laetsch",
"sponsor_slug": "theodore-laetsch",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06861920",
"publication_url": "https://clinicaltrials.gov/study/NCT06861920",
"title": "Targeting Interindividual Variability in NSAID Responses to Mitigate Chronic Pelvic Pain Risk in Dysmenorrhea (NSAID HEAL)",
"has_exemption": false,
"start_date": "2025-04-07",
"completion_date": "2030-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Endeavor Health",
"sponsor_slug": "endeavor-health",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06884423",
"publication_url": "https://clinicaltrials.gov/study/NCT06884423",
"title": "Infant Survival and Long-term Outcome Following Fetoscopic Endoluminal Tracheal Occlusion in Severe Left and Right Congenital Diaphragmatic Hernia, A Phase III Trial",
"has_exemption": false,
"start_date": "2025-04-07",
"completion_date": "2030-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Holly L Hedrick, MD",
"sponsor_slug": "holly-l-hedrick-md",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06892678",
"publication_url": "https://clinicaltrials.gov/study/NCT06892678",
"title": "DFMO Maintenance for Patients With Relapsed/Refractory Ewing Sarcoma or Osteosarcoma",
"has_exemption": false,
"start_date": "2025-04-07",
"completion_date": "2030-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Montefiore Medical Center",
"sponsor_slug": "montefiore-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06702033",
"publication_url": "https://clinicaltrials.gov/study/NCT06702033",
"title": "Phase II Trial of Surgery Followed by Risk-Directed Post-Operative Adjuvant Therapy for HPV-Related Oropharynx Squamous Cell Carcinoma: \"The Minimalist Trial-2 (MINT-2)\"",
"has_exemption": false,
"start_date": "2025-04-10",
"completion_date": "2030-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Washington University School of Medicine",
"sponsor_slug": "washington-university-school-of-medicine",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06915233",
"publication_url": "https://clinicaltrials.gov/study/NCT06915233",
"title": "A Prospective, Open-label, Randomized, Concurrent Active-controlled, Longitudinal, Multicenter, Phase 3 Clinical Study of the Safety and Efficacy of MACI in Patients With Symptomatic Chondral or Osteochondral Lesions of the Talus (MASCOT)",
"has_exemption": false,
"start_date": "2025-09-30",
"completion_date": "2030-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Vericel Corporation",
"sponsor_slug": "vericel-corporation",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06946576",
"publication_url": "https://clinicaltrials.gov/study/NCT06946576",
"title": "Infant Survival and Long-term Outcomes Following Fetoscopic Endoluminal Tracheal Occlusion in Severe Left and Right Congenital Diaphragmatic Hernia, A Phase III Trial",
"has_exemption": false,
"start_date": "2025-09-30",
"completion_date": "2030-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Oregon Health and Science University",
"sponsor_slug": "oregon-health-and-science-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07231497",
"publication_url": "https://clinicaltrials.gov/study/NCT07231497",
"title": "Cognitive Strategies in Early Psychosis 1",
"has_exemption": false,
"start_date": "2025-12-01",
"completion_date": "2030-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Minnesota",
"sponsor_slug": "university-of-minnesota",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07263022",
"publication_url": "https://clinicaltrials.gov/study/NCT07263022",
"title": "Cognitive Strategies in Early Psychosis 2",
"has_exemption": false,
"start_date": "2025-12-01",
"completion_date": "2030-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Minnesota",
"sponsor_slug": "university-of-minnesota",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06666348",
"publication_url": "https://clinicaltrials.gov/study/NCT06666348",
"title": "A Phase 1/2 Study of Mirdametinib and Vinblastine for Newly Diagnosed or Previously Untreated Patients With Pediatric Low-grade Glioma and Activation of the MAPK Pathway",
"has_exemption": false,
"start_date": "2025-12-31",
"completion_date": "2030-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "St. Justine's Hospital",
"sponsor_slug": "st-justines-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05763693",
"publication_url": "https://clinicaltrials.gov/study/NCT05763693",
"title": "Vitality in Infants Via Azithromycin for Neonates Trial",
"has_exemption": false,
"start_date": "2026-04-30",
"completion_date": "2030-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, San Francisco",
"sponsor_slug": "university-of-california-san-francisco",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07218575",
"publication_url": "https://clinicaltrials.gov/study/NCT07218575",
"title": "A Randomized, Placebo Controlled Double-Blind Trial of Everolimus for Improving Social Abilities in PTEN Germline Mutations",
"has_exemption": false,
"start_date": "2026-04-30",
"completion_date": "2030-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Boston Children’s Hospital",
"sponsor_slug": "boston-childrens-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07191717",
"publication_url": "https://clinicaltrials.gov/study/NCT07191717",
"title": "Phase II Minimal Residual Disease Study of Selective Estrogen Receptor Degrader Imlunestrant With Cyclin-Dependent Kinase (CDK) 4/6 Inhibitor Abemaciclib in Patients With ER+ Breast Cancer (MIRI)",
"has_exemption": false,
"start_date": "2026-04-30",
"completion_date": "2030-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Jonsson Comprehensive Cancer Center",
"sponsor_slug": "jonsson-comprehensive-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07212998",
"publication_url": "https://clinicaltrials.gov/study/NCT07212998",
"title": "Plasma Resuscitation Early for Evaluating Volume and Endotheliopathy of Thermal Injury (PREEVEnT) Trial",
"has_exemption": false,
"start_date": "2026-04-30",
"completion_date": "2030-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Jason Sperry",
"sponsor_slug": "jason-sperry",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03346694",
"publication_url": "https://clinicaltrials.gov/study/NCT03346694",
"title": "Reducing Surgical Site Infection Rates Using an Alternative Sternal Dressing",
"has_exemption": false,
"start_date": "2018-05-01",
"completion_date": "2030-05-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Stanford University",
"sponsor_slug": "stanford-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05285891",
"publication_url": "https://clinicaltrials.gov/study/NCT05285891",
"title": "Randomized, Blinded Discontinuation Trial of Ocrelizumab in Early Relapsing Multiple Sclerosis (AMS05)",
"has_exemption": false,
"start_date": "2023-01-12",
"completion_date": "2030-05-01",
"has_results": false,
"results_due": false,
"sponsor_name": "National Institute of Allergy and Infectious Diseases (NIAID)",
"sponsor_slug": "national-institute-of-allergy-and-infectious-diseases-niaid",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07118839",
"publication_url": "https://clinicaltrials.gov/study/NCT07118839",
"title": "MDMA-Assisted Therapy for Veterans With PTSD and Alcohol Use Disorder: A Randomized Controlled Trial",
"has_exemption": false,
"start_date": "2026-02-01",
"completion_date": "2030-05-01",
"has_results": false,
"results_due": false,
"sponsor_name": "VA Office of Research and Development",
"sponsor_slug": "va-office-of-research-and-development",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06585410",
"publication_url": "https://clinicaltrials.gov/study/NCT06585410",
"title": "A Phase 3 Randomized Study of Intralesional Cemiplimab Versus Primary Surgery in Participants With Early Stage Cutaneous Squamous Cell Carcinoma (CSCC)",
"has_exemption": false,
"start_date": "2025-01-02",
"completion_date": "2030-05-03",
"has_results": false,
"results_due": false,
"sponsor_name": "Regeneron Pharmaceuticals",
"sponsor_slug": "regeneron-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05692180",
"publication_url": "https://clinicaltrials.gov/study/NCT05692180",
"title": "Efficacy and Safety of Benralizumab in Paediatric Patients With Severe Eosinophilic Asthma (DOMINICA)",
"has_exemption": false,
"start_date": "2023-04-05",
"completion_date": "2030-05-05",
"has_results": false,
"results_due": false,
"sponsor_name": "AstraZeneca",
"sponsor_slug": "astrazeneca",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06663722",
"publication_url": "https://clinicaltrials.gov/study/NCT06663722",
"title": "A Phase II b Study of Axatilimab in Combination With Extracorporeal Photopheresis (ECP) in Chronic Graft-versus-Host Disease",
"has_exemption": false,
"start_date": "2025-05-05",
"completion_date": "2030-05-05",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Miami",
"sponsor_slug": "university-of-miami",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04821310",
"publication_url": "https://clinicaltrials.gov/study/NCT04821310",
"title": "AN EXPLORATORY, MULTICENTER, RANDOMIZED, DOUBLE BLIND STUDY OF CLINICAL OUTCOMES, TOLERABILITY, AND SAFETY OF 2 DOSES OF ORAL PANTOPRAZOLE IN PEDIATRIC PARTICIPANTS AGED 1 TO 11 YEARS AND 12 TO 17 YEARS WHO REQUIRE MAINTENANCE THERAPY FOR HEALED EROSIVE ESOPHAGITIS",
"has_exemption": false,
"start_date": "2022-01-13",
"completion_date": "2030-05-09",
"has_results": false,
"results_due": false,
"sponsor_name": "Pfizer",
"sponsor_slug": "pfizer",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05061550",
"publication_url": "https://clinicaltrials.gov/study/NCT05061550",
"title": "A Phase II, Open-label, Multicentre, Randomised Study of Neoadjuvant and Adjuvant Treatment in Patients With Resectable, Early-stage (II to IIIB) Non-small Cell Lung Cancer (NeoCOAST-2)",
"has_exemption": false,
"start_date": "2022-04-14",
"completion_date": "2030-05-09",
"has_results": false,
"results_due": false,
"sponsor_name": "AstraZeneca",
"sponsor_slug": "astrazeneca",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07222189",
"publication_url": "https://clinicaltrials.gov/study/NCT07222189",
"title": "A Multinational, Multicenter Extension Study to Investigate the Long-term Safety, Tolerability and Efficacy of Balinatunfib in Adults With Crohn's Disease or Ulcerative Colitis",
"has_exemption": false,
"start_date": "2025-12-24",
"completion_date": "2030-05-10",
"has_results": false,
"results_due": false,
"sponsor_name": "Sanofi",
"sponsor_slug": "sanofi",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07154290",
"publication_url": "https://clinicaltrials.gov/study/NCT07154290",
"title": "A Phase 2 Study to Investigate Ubamatamab With and Without REGN7075 in Treatment-Experienced Participants With Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)",
"has_exemption": false,
"start_date": "2026-01-26",
"completion_date": "2030-05-17",
"has_results": false,
"results_due": false,
"sponsor_name": "Regeneron Pharmaceuticals",
"sponsor_slug": "regeneron-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06841354",
"publication_url": "https://clinicaltrials.gov/study/NCT06841354",
"title": "A Phase 3, Randomized, Open-label Study Comparing Efficacy and Safety of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as a Monotherapy and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With Previously Untreated Locally Recurrent Unresectable or Metastatic Triple-Negative Breast Cancer Expressing PD-L1 at CPS Less Than 10 (TroFuse-011)",
"has_exemption": false,
"start_date": "2025-03-16",
"completion_date": "2030-05-18",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06932757",
"publication_url": "https://clinicaltrials.gov/study/NCT06932757",
"title": "Phase 2 Trial of Adjuvant Quisinostat in High-Risk Uveal Melanoma",
"has_exemption": false,
"start_date": "2025-05-27",
"completion_date": "2030-05-27",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Miami",
"sponsor_slug": "university-of-miami",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07052903",
"publication_url": "https://clinicaltrials.gov/study/NCT07052903",
"title": "TRITON-CM: A Phase 3 Global, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Nucresiran in Patients With Transthyretin-Mediated Amyloidosis With Cardiomyopathy (ATTR Amyloidosis With Cardiomyopathy)",
"has_exemption": false,
"start_date": "2025-07-02",
"completion_date": "2030-05-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Alnylam Pharmaceuticals",
"sponsor_slug": "alnylam-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05775367",
"publication_url": "https://clinicaltrials.gov/study/NCT05775367",
"title": "Cochlear Implantation in Infants and Toddlers With Single-Sided Deafness",
"has_exemption": false,
"start_date": "2023-07-07",
"completion_date": "2030-05-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of North Carolina, Chapel Hill",
"sponsor_slug": "university-of-north-carolina-chapel-hill",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT02115295",
"publication_url": "https://clinicaltrials.gov/study/NCT02115295",
"title": "Phase II Study of Cladribine Plus Idarubicin Plus Cytarabine (ARAC) in Patients With AML, HR MDS, or Myeloid Blast Phase of CML",
"has_exemption": false,
"start_date": "2014-05-19",
"completion_date": "2030-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT02310399",
"publication_url": "https://clinicaltrials.gov/study/NCT02310399",
"title": "Auditory Brainstem Implant (ABI) in Children With No Cochleae or Auditory Nerves",
"has_exemption": false,
"start_date": "2014-05-31",
"completion_date": "2030-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "NYU Langone Health",
"sponsor_slug": "nyu-langone-health",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT03394365",
"publication_url": "https://clinicaltrials.gov/study/NCT03394365",
"title": "Multicenter, Open-Label, Phase 3 Study of Tabelecleucel for Solid Organ or Allogeneic Hematopoietic Cell Transplant Subjects With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure of Rituximab or Rituximab and Chemotherapy",
"has_exemption": false,
"start_date": "2017-12-29",
"completion_date": "2030-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Pierre Fabre Medicament",
"sponsor_slug": "pierre-fabre-medicament",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03618186",
"publication_url": "https://clinicaltrials.gov/study/NCT03618186",
"title": "Neuroimaging Study",
"has_exemption": false,
"start_date": "2018-11-26",
"completion_date": "2030-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Mayo Clinic",
"sponsor_slug": "mayo-clinic",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03821857",
"publication_url": "https://clinicaltrials.gov/study/NCT03821857",
"title": "Sex-Specific Effects of Endocrine Disruption on Aging and Alzheimer's Disease",
"has_exemption": false,
"start_date": "2019-06-27",
"completion_date": "2030-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Mayo Clinic",
"sponsor_slug": "mayo-clinic",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03972202",
"publication_url": "https://clinicaltrials.gov/study/NCT03972202",
"title": "The Role of Cerebellum in Speech",
"has_exemption": false,
"start_date": "2019-09-15",
"completion_date": "2030-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, San Francisco",
"sponsor_slug": "university-of-california-san-francisco",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05951179",
"publication_url": "https://clinicaltrials.gov/study/NCT05951179",
"title": "A Phase 2, Open-Label Study to Evaluate the Safety and Efficacy of Intravesical Instillation of TARA-002 in Adults With High-Grade Non-Muscle Invasive Bladder Cancer",
"has_exemption": false,
"start_date": "2023-09-15",
"completion_date": "2030-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Protara Therapeutics",
"sponsor_slug": "protara-therapeutics",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06492304",
"publication_url": "https://clinicaltrials.gov/study/NCT06492304",
"title": "A Phase 1/2 Dose Evaluation and Cohort Expansion Study of the Safety and Efficacy of Anti-CD70 Allogeneic CRISPR-Cas9-Engineered T Cells (CTX131) in Adult Subjects With Relapsed/Refractory Hematologic Malignancies",
"has_exemption": false,
"start_date": "2024-08-13",
"completion_date": "2030-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "CRISPR Therapeutics",
"sponsor_slug": "crispr-therapeutics",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06851338",
"publication_url": "https://clinicaltrials.gov/study/NCT06851338",
"title": "Pediatric Down Syndrome Post-Approval Study",
"has_exemption": false,
"start_date": "2025-02-28",
"completion_date": "2030-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Inspire Medical Systems, Inc.",
"sponsor_slug": "inspire-medical-systems-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07010692",
"publication_url": "https://clinicaltrials.gov/study/NCT07010692",
"title": "Using Fractional Lasers and Tirbanibulin Ointment to Treat Keratinocyte Carcinomas",
"has_exemption": false,
"start_date": "2025-05-16",
"completion_date": "2030-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Bruce Robinson, MD",
"sponsor_slug": "bruce-robinson-md",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06876662",
"publication_url": "https://clinicaltrials.gov/study/NCT06876662",
"title": "Long-Term Safety of Pirtobrutinib in Participants From Study LOXO-BTK-18001 With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Non-Hodgkin Lymphoma",
"has_exemption": false,
"start_date": "2025-05-20",
"completion_date": "2030-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Eli Lilly and Company",
"sponsor_slug": "eli-lilly-and-company",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06876649",
"publication_url": "https://clinicaltrials.gov/study/NCT06876649",
"title": "A Master Protocol to Evaluate the Long-Term Safety of Pirtobrutinib",
"has_exemption": false,
"start_date": "2025-05-20",
"completion_date": "2030-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Eli Lilly and Company",
"sponsor_slug": "eli-lilly-and-company",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06961955",
"publication_url": "https://clinicaltrials.gov/study/NCT06961955",
"title": "FAST NOVEMBER: A Phase II Randomized Trial of a 5 vs. 9-day Course of Whole Breast Radiotherapy With Boost for Early-stage Breast Cancer",
"has_exemption": false,
"start_date": "2025-05-21",
"completion_date": "2030-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Utah",
"sponsor_slug": "university-of-utah",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07162181",
"publication_url": "https://clinicaltrials.gov/study/NCT07162181",
"title": "Long-Term Safety of Pirtobrutinib in Participants From Study J2N-MC-JZNJ With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Non-Hodgkin Lymphoma",
"has_exemption": false,
"start_date": "2025-08-07",
"completion_date": "2030-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Eli Lilly and Company",
"sponsor_slug": "eli-lilly-and-company",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06814496",
"publication_url": "https://clinicaltrials.gov/study/NCT06814496",
"title": "RAdiation comBined With BIspecific T-Cell Engager in DLL3 Expressing Tumors (RABBIT) Study: A Phase I/II Study of AMG757 / Tarlatamab and Concurrent Radiation Therapy in Tumors With High Prevalence of DLL3",
"has_exemption": false,
"start_date": "2025-09-08",
"completion_date": "2030-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Arizona",
"sponsor_slug": "university-of-arizona",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07186842",
"publication_url": "https://clinicaltrials.gov/study/NCT07186842",
"title": "First-in-human, Open-label, Multi-site, Phase I/IIa, Dose Escalation Trial With Expansion Cohorts to Evaluate Safety and Preliminary Efficacy of BNT329 in Participants With Advanced Solid Tumors Known to Express CA19-9",
"has_exemption": false,
"start_date": "2025-11-18",
"completion_date": "2030-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Biontech SE",
"sponsor_slug": "biontech-se",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07224438",
"publication_url": "https://clinicaltrials.gov/study/NCT07224438",
"title": "Kisspeptin Administration Subcutaneously to Patients With Hypothalamic Amenorrhea",
"has_exemption": false,
"start_date": "2025-12-31",
"completion_date": "2030-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Stephanie B. Seminara, MD",
"sponsor_slug": "stephanie-b-seminara-md",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07097363",
"publication_url": "https://clinicaltrials.gov/study/NCT07097363",
"title": "A Pilot Study of Epcoritamab With Dose Adjusted Etoposide, Cyclophosphamide, Vincristine, Doxorubicin, Prednisone and Rituximab (EPOCH-R) for Upfront Treatment of Aggressive B-Cell Non-Hodgkin Lymphomas",
"has_exemption": false,
"start_date": "2026-01-01",
"completion_date": "2030-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Washington",
"sponsor_slug": "university-of-washington",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07218341",
"publication_url": "https://clinicaltrials.gov/study/NCT07218341",
"title": "Long-Term Safety of Pirtobrutinib in Participants From Study LOXO-BTK-20020 With BTKi Pretreated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma",
"has_exemption": false,
"start_date": "2026-03-31",
"completion_date": "2030-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Eli Lilly and Company",
"sponsor_slug": "eli-lilly-and-company",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07087938",
"publication_url": "https://clinicaltrials.gov/study/NCT07087938",
"title": "Safety and Behavioral Pharmacology of Cannabichromene as an Adjunct to Rheumatoid Arthritis Treatment; Effects on Inflammatory Markers and Rheumatoid Arthritis Disease Activity",
"has_exemption": false,
"start_date": "2028-07-15",
"completion_date": "2030-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Crystal Lederhos Smith",
"sponsor_slug": "crystal-lederhos-smith",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04900623",
"publication_url": "https://clinicaltrials.gov/study/NCT04900623",
"title": "Risk-adapted Therapy in HPV+ Oropharyngeal Cancer Using Circulating Tumor (ct)HPV DNA Profile - The ReACT Study",
"has_exemption": false,
"start_date": "2021-07-02",
"completion_date": "2030-06-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Jonathan Schoenfeld, MD, MPH",
"sponsor_slug": "jonathan-schoenfeld-md-mph",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06872333",
"publication_url": "https://clinicaltrials.gov/study/NCT06872333",
"title": "Allogeneic Hematopoietic Stem Cell Transplant for Patients With High Risk Hemoglobinopathies and Other Red Cell Transfusion Dependent Disorders",
"has_exemption": false,
"start_date": "2024-11-19",
"completion_date": "2030-06-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Masonic Cancer Center, University of Minnesota",
"sponsor_slug": "masonic-cancer-center-university-of-minnesota",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06810778",
"publication_url": "https://clinicaltrials.gov/study/NCT06810778",
"title": "Phase I/II Study of Duvelisib and Venetoclax in Patients With Relapsed or Refractory Peripheral T-cell Lymphoma (PTCL)",
"has_exemption": false,
"start_date": "2025-05-02",
"completion_date": "2030-06-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Jonsson Comprehensive Cancer Center",
"sponsor_slug": "jonsson-comprehensive-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07060066",
"publication_url": "https://clinicaltrials.gov/study/NCT07060066",
"title": "Bilateral Prefrontal and Insular TMS for Depression in Schizophrenia",
"has_exemption": false,
"start_date": "2025-09-01",
"completion_date": "2030-06-01",
"has_results": false,
"results_due": false,
"sponsor_name": "The University of Texas Health Science Center, Houston",
"sponsor_slug": "the-university-of-texas-health-science-center-houston",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07142551",
"publication_url": "https://clinicaltrials.gov/study/NCT07142551",
"title": "Supraphysiologic Testosterone Priming Induces Darolutamide Extended Response Via Modulation of ANdrogen Receptor (the SPIDERMAN Trial)",
"has_exemption": false,
"start_date": "2025-12-30",
"completion_date": "2030-06-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins",
"sponsor_slug": "sidney-kimmel-comprehensive-cancer-center-at-johns-hopkins",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06996730",
"publication_url": "https://clinicaltrials.gov/study/NCT06996730",
"title": "A Double-Blind, Placebo-Controlled, Double-Dummy Study of Donanemab and RG6289 in PSEN1 E280A Mutation Carriers, and in Non-Randomized, Placebo-Treated Non-Carriers From the Same Kindred, to Evaluate the Efficacy and Safety of Donanemab, RG6289, or the Combination of Donanemab and RG6289, in the Treatment of Autosomal-Dominant Alzheimer's Disease",
"has_exemption": false,
"start_date": "2026-01-15",
"completion_date": "2030-06-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Banner Health",
"sponsor_slug": "banner-health",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06800092",
"publication_url": "https://clinicaltrials.gov/study/NCT06800092",
"title": "Sildenafil to Prevent and Reduce Cancer Related Cognitive Impairment",
"has_exemption": false,
"start_date": "2026-03-15",
"completion_date": "2030-06-01",
"has_results": false,
"results_due": false,
"sponsor_name": "The University of Texas Medical Branch, Galveston",
"sponsor_slug": "the-university-of-texas-medical-branch-galveston",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04457076",
"publication_url": "https://clinicaltrials.gov/study/NCT04457076",
"title": "A Phase 3, Prospective, Multi-Center, Single-Arm, Open-Label Study to Evaluate LevoCept™, a Long-Acting Reversible Intrauterine System for Contraceptive Efficacy, Safety, and Tolerability",
"has_exemption": false,
"start_date": "2026-06-01",
"completion_date": "2030-06-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Sebela Women's Health Inc.",
"sponsor_slug": "sebela-womens-health-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05998408",
"publication_url": "https://clinicaltrials.gov/study/NCT05998408",
"title": "A Phase I/II Study of the JAK1/2 Inhibitor Ruxolitinib for Relapsed / Refractory Immune Bone Marrow Failure",
"has_exemption": false,
"start_date": "2024-02-20",
"completion_date": "2030-06-03",
"has_results": false,
"results_due": false,
"sponsor_name": "National Heart, Lung, and Blood Institute (NHLBI)",
"sponsor_slug": "national-heart-lung-and-blood-institute-nhlbi",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07019454",
"publication_url": "https://clinicaltrials.gov/study/NCT07019454",
"title": "Baystate Health Physician Sponsored - Investigational Device Exception: Physician Modified Endovascular Grafts for the Treatment of Elective, Symptomatic or Ruptured Juxtarenal Aortic Aneurysms",
"has_exemption": false,
"start_date": "2025-06-03",
"completion_date": "2030-06-03",
"has_results": false,
"results_due": false,
"sponsor_name": "Baystate Medical Center",
"sponsor_slug": "baystate-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07226999",
"publication_url": "https://clinicaltrials.gov/study/NCT07226999",
"title": "A GLOBAL PHASE 2/3 INTERVENTIONAL STUDY OF PF-08634404 IN COMBINATION WITH CHEMOTHERAPY IN PARTICIPANTS WITH EXTENSIVE STAGE SMALL CELL LUNG CANCER",
"has_exemption": false,
"start_date": "2025-11-17",
"completion_date": "2030-06-14",
"has_results": false,
"results_due": false,
"sponsor_name": "Pfizer",
"sponsor_slug": "pfizer",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05987449",
"publication_url": "https://clinicaltrials.gov/study/NCT05987449",
"title": "A Phase I/II Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of NXT007 in Persons With Severe or Moderate Hemophilia A",
"has_exemption": false,
"start_date": "2023-09-21",
"completion_date": "2030-06-16",
"has_results": false,
"results_due": false,
"sponsor_name": "Hoffmann-La Roche",
"sponsor_slug": "hoffmann-la-roche",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07116616",
"publication_url": "https://clinicaltrials.gov/study/NCT07116616",
"title": "A Phase 1/2, Open-label, Multicenter Study of mRNA-2808 in Participants With Relapsed or Refractory Multiple Myeloma",
"has_exemption": false,
"start_date": "2025-09-30",
"completion_date": "2030-06-17",
"has_results": false,
"results_due": false,
"sponsor_name": "ModernaTX, Inc.",
"sponsor_slug": "modernatx-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06077760",
"publication_url": "https://clinicaltrials.gov/study/NCT06077760",
"title": "A Phase 3, Randomized, Double-blind, Placebo- and Active-Comparator-Controlled Clinical Study of Adjuvant V940 (mRNA-4157) Plus Pembrolizumab Versus Adjuvant Placebo Plus Pembrolizumab in Participants With Resected Stage II, IIIA, IIIB (N2) Non-small Cell Lung Cancer (INTerpath-002)",
"has_exemption": false,
"start_date": "2023-12-06",
"completion_date": "2030-06-25",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05335876",
"publication_url": "https://clinicaltrials.gov/study/NCT05335876",
"title": "Long-term Follow-up of Patients With Spinal Muscular Atrophy Treated With OAV101 IT or OAV101 IV in Clinical Trials",
"has_exemption": false,
"start_date": "2022-12-19",
"completion_date": "2030-06-26",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06578247",
"publication_url": "https://clinicaltrials.gov/study/NCT06578247",
"title": "A Phase 3, Double-Blind, Randomized, Placebo-Controlled Trial Of Quizartinib Administered in Combination With Induction and Consolidation Chemotherapy and Administered as Maintenance Therapy in Adult Patients With Newly Diagnosed FLT3-ITD Negative Acute Myeloid Leukemia",
"has_exemption": false,
"start_date": "2024-11-19",
"completion_date": "2030-06-26",
"has_results": false,
"results_due": false,
"sponsor_name": "Daiichi Sankyo",
"sponsor_slug": "daiichi-sankyo",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07029828",
"publication_url": "https://clinicaltrials.gov/study/NCT07029828",
"title": "A LONG-TERM, DOUBLE-BLIND EXTENSION STUDY TO INVESTIGATE THE SAFETY AND EFFICACY OF RITLECITINIB IN PARTICIPANTS WITH SEVERE ALOPECIA AREATA WHO PREVIOUSLY COMPLETED STUDIES B7981027 OR B7981031",
"has_exemption": false,
"start_date": "2025-09-10",
"completion_date": "2030-06-26",
"has_results": false,
"results_due": false,
"sponsor_name": "Pfizer",
"sponsor_slug": "pfizer",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07215585",
"publication_url": "https://clinicaltrials.gov/study/NCT07215585",
"title": "A Phase III, Multicentre, Open-Label, Randomised Study Evaluating the Efficacy and Safety of R-mini-CHOP x2 Followed by AZD0486 Versus R-mini-CHOP x6 in Elderly or Unfit Participants With Newly Diagnosed Large B-cell Lymphoma (SOUNDTRACK-D2)",
"has_exemption": false,
"start_date": "2025-11-11",
"completion_date": "2030-06-27",
"has_results": false,
"results_due": false,
"sponsor_name": "AstraZeneca",
"sponsor_slug": "astrazeneca",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04004169",
"publication_url": "https://clinicaltrials.gov/study/NCT04004169",
"title": "Closed-Loop Deep Brain Stimulation for Treatment-Resistant Depression",
"has_exemption": false,
"start_date": "2019-07-18",
"completion_date": "2030-06-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Andrew Krystal",
"sponsor_slug": "andrew-krystal",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05161195",
"publication_url": "https://clinicaltrials.gov/study/NCT05161195",
"title": "A Post-trial Access Roll-over Study to Allow Access to Ribociclib (LEE011) for Patients Who Are on Ribociclib Treatment in Novartis-sponsored Study",
"has_exemption": false,
"start_date": "2022-07-07",
"completion_date": "2030-06-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07127913",
"publication_url": "https://clinicaltrials.gov/study/NCT07127913",
"title": "Closed-Loop Deep Brain Stimulation for Bipolar Depression (PReSiDio-BP)",
"has_exemption": false,
"start_date": "2025-07-16",
"completion_date": "2030-06-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Andrew Krystal",
"sponsor_slug": "andrew-krystal",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06994845",
"publication_url": "https://clinicaltrials.gov/study/NCT06994845",
"title": "A Single-arm, Multicenter, Phase III Study to Assess Efficacy, Pharmacokinetics, Safety and Tolerability of Iptacopan in Pediatric Patients of 2 to <18 Years of Age With Primary Immunoglobulin A Nephropathy (IgAN)",
"has_exemption": false,
"start_date": "2025-11-27",
"completion_date": "2030-06-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03971669",
"publication_url": "https://clinicaltrials.gov/study/NCT03971669",
"title": "Collection of Blood Samples for In-Vitro Studies from Healthy Adult Blood Donors Who Have Received Oral Typhoid Vaccine (TY21A)",
"has_exemption": false,
"start_date": "2004-01-16",
"completion_date": "2030-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Maryland, Baltimore",
"sponsor_slug": "university-of-maryland-baltimore",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT03547973",
"publication_url": "https://clinicaltrials.gov/study/NCT03547973",
"title": "A Phase II Open-Label Study of Sacituzumab Govitecan in Unresectable Locally Advanced/Metastatic Urothelial Cancer",
"has_exemption": false,
"start_date": "2018-08-13",
"completion_date": "2030-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Gilead Sciences",
"sponsor_slug": "gilead-sciences",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04305145",
"publication_url": "https://clinicaltrials.gov/study/NCT04305145",
"title": "Phase II Study of Infliximab for the Treatment of Immune Checkpoint Inhibitor Colitis",
"has_exemption": false,
"start_date": "2020-08-31",
"completion_date": "2030-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Massachusetts General Hospital",
"sponsor_slug": "massachusetts-general-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04639050",
"publication_url": "https://clinicaltrials.gov/study/NCT04639050",
"title": "A Phase Ib/IIa, Randomized, Double Blind, Placebo-Controlled, Multiple Ascending Dose, Parallel-Group Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7126209 Following Intravenous Infusion in Patients With Prodromal or Mild to Moderate Alzheimer's Disease",
"has_exemption": false,
"start_date": "2021-03-15",
"completion_date": "2030-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Hoffmann-La Roche",
"sponsor_slug": "hoffmann-la-roche",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05422222",
"publication_url": "https://clinicaltrials.gov/study/NCT05422222",
"title": "A Phase 3 Study Evaluating the Pharmacokinetics, Safety, and Tolerability of VX-121/Tezacaftor/Deutivacaftor Triple Combination Therapy in Cystic Fibrosis Subjects 1 Through 11 Years of Age",
"has_exemption": false,
"start_date": "2022-06-21",
"completion_date": "2030-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Vertex Pharmaceuticals Incorporated",
"sponsor_slug": "vertex-pharmaceuticals-incorporated",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06118892",
"publication_url": "https://clinicaltrials.gov/study/NCT06118892",
"title": "Post-Market Evaluation of the MISHA® Knee System for Symptom Relief in Subjects With Medial Knee Osteoarthritis",
"has_exemption": false,
"start_date": "2023-11-03",
"completion_date": "2030-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Moximed",
"sponsor_slug": "moximed",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06384573",
"publication_url": "https://clinicaltrials.gov/study/NCT06384573",
"title": "The Dominantly Inherited Alzheimer Network Trials Unit (DIAN-TU) Amyloid Removal Trial (ART): A Phase IIIb/IV Open-Label Study of Lecanemab to Evaluate Prevention and Progression of Dominantly Inherited Alzheimer's Disease",
"has_exemption": false,
"start_date": "2024-06-10",
"completion_date": "2030-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Washington University School of Medicine",
"sponsor_slug": "washington-university-school-of-medicine",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06122974",
"publication_url": "https://clinicaltrials.gov/study/NCT06122974",
"title": "A RanDomized Controlled Trial of the Drug Eluting TEmporary Spur StEnt System vs PERcutaneous Balloon Angioplasty for the TReatment of CriTical Limb Ischemia",
"has_exemption": false,
"start_date": "2024-06-30",
"completion_date": "2030-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "ReFlow Medical, Inc.",
"sponsor_slug": "reflow-medical-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06904313",
"publication_url": "https://clinicaltrials.gov/study/NCT06904313",
"title": "Evaluation of Ultralow Dose PET Imaging for Detecting PSMA Expression",
"has_exemption": false,
"start_date": "2025-05-12",
"completion_date": "2030-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Akiva Mintz",
"sponsor_slug": "akiva-mintz",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06956391",
"publication_url": "https://clinicaltrials.gov/study/NCT06956391",
"title": "Evaluation of Ultralow Dose PET Imaging for Detecting 18F-FDG Uptake",
"has_exemption": false,
"start_date": "2025-05-12",
"completion_date": "2030-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Akiva Mintz",
"sponsor_slug": "akiva-mintz",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07012993",
"publication_url": "https://clinicaltrials.gov/study/NCT07012993",
"title": "Evaluation of Ultralow Dose PET Imaging for Detecting Amyloid Tracer Uptake",
"has_exemption": false,
"start_date": "2025-05-20",
"completion_date": "2030-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Akiva Mintz",
"sponsor_slug": "akiva-mintz",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07038343",
"publication_url": "https://clinicaltrials.gov/study/NCT07038343",
"title": "A Phase 1/2, First-in-human Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors",
"has_exemption": false,
"start_date": "2025-06-04",
"completion_date": "2030-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Avenzo Therapeutics, Inc.",
"sponsor_slug": "avenzo-therapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06464926",
"publication_url": "https://clinicaltrials.gov/study/NCT06464926",
"title": "A Prospective Randomized Controlled Trial of Chronic Nausea and Vomiting in Patients With Normal Gastric Emptying Using the Enterra® Therapy System",
"has_exemption": false,
"start_date": "2025-06-23",
"completion_date": "2030-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Enterra Medical, Inc.",
"sponsor_slug": "enterra-medical-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06474273",
"publication_url": "https://clinicaltrials.gov/study/NCT06474273",
"title": "A Multicenter Randomized Controlled Trial to Treat Acute t Cell Mediated Rejection in Kidney and Kidney-pancreas Transplant Recipients",
"has_exemption": false,
"start_date": "2025-06-30",
"completion_date": "2030-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Sydney",
"sponsor_slug": "university-of-sydney",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06953089",
"publication_url": "https://clinicaltrials.gov/study/NCT06953089",
"title": "A Phase II, Multicenter, Open-Label Trial of DB-1311 in Combination With BNT327 or DB-1305 in Participants With Advanced/Metastatic Solid Tumors",
"has_exemption": false,
"start_date": "2025-07-18",
"completion_date": "2030-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "DualityBio Inc.",
"sponsor_slug": "dualitybio-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07076342",
"publication_url": "https://clinicaltrials.gov/study/NCT07076342",
"title": "Mechanistic Clinical Trial Evaluating the Role of the Metabotropic Glutamate Receptor Subtype 5 (mGluR5) in the Antidepressant Mechanism of Cognitive Behavioral Therapy for Insomnia (CBT-I)",
"has_exemption": false,
"start_date": "2025-08-01",
"completion_date": "2030-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Stony Brook University",
"sponsor_slug": "stony-brook-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07212686",
"publication_url": "https://clinicaltrials.gov/study/NCT07212686",
"title": "An Open-Label, Single-Center Study of Synthetic Angiotensin II/Giapreza in Pediatric Patients With Refractory Hypotension Despite Receiving Fluid Therapy and Vasoactive Therapy",
"has_exemption": false,
"start_date": "2025-09-09",
"completion_date": "2030-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Todd Sweberg",
"sponsor_slug": "todd-sweberg",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06520098",
"publication_url": "https://clinicaltrials.gov/study/NCT06520098",
"title": "Benefit of Venetoclax Addition (\"Benefit VA\") in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)",
"has_exemption": false,
"start_date": "2025-10-01",
"completion_date": "2030-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "VA Office of Research and Development",
"sponsor_slug": "va-office-of-research-and-development",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07067463",
"publication_url": "https://clinicaltrials.gov/study/NCT07067463",
"title": "A Phase 3, Randomized, Double-blind, Efficacy and Safety Study Comparing Orelabrutinib to Placebo in Patients With Primary Progressive Multiple Sclerosis",
"has_exemption": false,
"start_date": "2025-12-31",
"completion_date": "2030-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Zenas BioPharma (USA), LLC",
"sponsor_slug": "zenas-biopharma-usa-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07084441",
"publication_url": "https://clinicaltrials.gov/study/NCT07084441",
"title": "Comparison of Outcomes of Management of Bowel Obstruction",
"has_exemption": false,
"start_date": "2025-12-31",
"completion_date": "2030-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Washington",
"sponsor_slug": "university-of-washington",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07096297",
"publication_url": "https://clinicaltrials.gov/study/NCT07096297",
"title": "A Phase II Study of Luspatercept Plus Darbepoetin Alfa in Non-mutated SF3B1 Lower-risk Myelodysplastic Syndromes",
"has_exemption": false,
"start_date": "2025-12-31",
"completion_date": "2030-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Yale University",
"sponsor_slug": "yale-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07135596",
"publication_url": "https://clinicaltrials.gov/study/NCT07135596",
"title": "Research on the Effectiveness and Safety of Treatment With OviTex® PRS - a Breast Reconstruction Evaluation",
"has_exemption": false,
"start_date": "2025-12-31",
"completion_date": "2030-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Tela Bio Inc",
"sponsor_slug": "tela-bio-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07223814",
"publication_url": "https://clinicaltrials.gov/study/NCT07223814",
"title": "Bleximenib or Placebo in Combination With Standard Induction and Consolidation Therapy Followed by Maintenance for the Treatment of Patients With Newly Diagnosed KMT2A-rearranged or NPM1-mutant Acute Myeloid Leukemia Eligible for Intensive Chemotherapy: a Double-blind Phase 3 Study",
"has_exemption": false,
"start_date": "2025-12-31",
"completion_date": "2030-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Stichting Hemato-Oncologie voor Volwassenen Nederland",
"sponsor_slug": "stichting-hemato-oncologie-voor-volwassenen-nederland",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07210606",
"publication_url": "https://clinicaltrials.gov/study/NCT07210606",
"title": "Central Apnea in Heart Failure: Physiological Mechanisms to Inform Treatment",
"has_exemption": false,
"start_date": "2026-01-01",
"completion_date": "2030-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "VA Office of Research and Development",
"sponsor_slug": "va-office-of-research-and-development",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06699966",
"publication_url": "https://clinicaltrials.gov/study/NCT06699966",
"title": "Stony Brook Medicine Anti-Inflammatory Trial",
"has_exemption": false,
"start_date": "2026-01-31",
"completion_date": "2030-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Stony Brook University",
"sponsor_slug": "stony-brook-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07214649",
"publication_url": "https://clinicaltrials.gov/study/NCT07214649",
"title": "A Prospective Study Using Patient-Derived Extrahepatic Cholangiocyte Organoids for Refractory Bile Leaks",
"has_exemption": false,
"start_date": "2026-01-31",
"completion_date": "2030-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Fondazione Policlinico Universitario Agostino Gemelli IRCCS",
"sponsor_slug": "fondazione-policlinico-universitario-agostino-gemelli-irccs",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06131502",
"publication_url": "https://clinicaltrials.gov/study/NCT06131502",
"title": "ExAblate MR-guided Focused Ultrasound Bilateral Anterior Capsulotomy for Treatment of Obsessive-Compulsive Disorder",
"has_exemption": false,
"start_date": "2026-04-30",
"completion_date": "2030-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Brigham and Women's Hospital",
"sponsor_slug": "brigham-and-womens-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06545695",
"publication_url": "https://clinicaltrials.gov/study/NCT06545695",
"title": "Epidermal Growth Factor Receptor Inhibition for Keratinopathies",
"has_exemption": false,
"start_date": "2026-12-01",
"completion_date": "2030-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Northwestern University",
"sponsor_slug": "northwestern-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04814082",
"publication_url": "https://clinicaltrials.gov/study/NCT04814082",
"title": "Prospective Functional, Gait, and Outcome Comparison Study of Medial Pivot",
"has_exemption": false,
"start_date": "2021-02-01",
"completion_date": "2030-07-01",
"has_results": false,
"results_due": false,
"sponsor_name": "LifeBridge Health",
"sponsor_slug": "lifebridge-health",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05564377",
"publication_url": "https://clinicaltrials.gov/study/NCT05564377",
"title": "Molecular Analysis for Combination Therapy Choice (ComboMATCH)",
"has_exemption": false,
"start_date": "2023-04-07",
"completion_date": "2030-07-01",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07121595",
"publication_url": "https://clinicaltrials.gov/study/NCT07121595",
"title": "PRECEDENT: Pilot Phase II Study of Personalized Radiation to the Contralateral Neck Directed by Sentinel Node Evaluation in Lateralized Oral Cavity Squamous Cell Carcinoma",
"has_exemption": false,
"start_date": "2025-07-17",
"completion_date": "2030-07-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Michigan Rogel Cancer Center",
"sponsor_slug": "university-of-michigan-rogel-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06525389",
"publication_url": "https://clinicaltrials.gov/study/NCT06525389",
"title": "Liposomal Amphotericin B and Flucytosine Antifungal Strategy for Talaromycosis (LAmB-FAST)",
"has_exemption": false,
"start_date": "2025-12-01",
"completion_date": "2030-07-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Duke University",
"sponsor_slug": "duke-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04715646",
"publication_url": "https://clinicaltrials.gov/study/NCT04715646",
"title": "Open-Label, Single-Arm, Multicenter Study to Evaluate Long-Term Safety and Tolerability of Brivaracetam Used as Adjunctive Treatment in Pediatric Study Participants With Epilepsy",
"has_exemption": false,
"start_date": "2021-03-11",
"completion_date": "2030-07-08",
"has_results": false,
"results_due": false,
"sponsor_name": "UCB Biopharma SRL",
"sponsor_slug": "ucb-biopharma-srl",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04684602",
"publication_url": "https://clinicaltrials.gov/study/NCT04684602",
"title": "Evaluation of the Safety, Tolerability and Efficacy of Regenerative Therapy for the Treatment of Various Chronic and Acute Conditions",
"has_exemption": false,
"start_date": "2020-07-09",
"completion_date": "2030-07-09",
"has_results": false,
"results_due": false,
"sponsor_name": "Thomas Advanced Medical LLC",
"sponsor_slug": "thomas-advanced-medical-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07227311",
"publication_url": "https://clinicaltrials.gov/study/NCT07227311",
"title": "A Phase 2, Multicenter, Open Label, Non-randomized Study to Evaluate the Efficacy and Safety of Extended Dosing of Belantamab Mafodotin in Different Combinations With Standard of Care Regimens in Participants With Relapsed-refractory Multiple Myeloma (DREAMM-15)",
"has_exemption": false,
"start_date": "2026-01-14",
"completion_date": "2030-07-10",
"has_results": false,
"results_due": false,
"sponsor_name": "GlaxoSmithKline",
"sponsor_slug": "glaxosmithkline",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07089901",
"publication_url": "https://clinicaltrials.gov/study/NCT07089901",
"title": "Project DEDUCE: Digital Envirotyping to Develop Understanding of Cigarette Smoking and the Environment",
"has_exemption": false,
"start_date": "2025-11-01",
"completion_date": "2030-07-14",
"has_results": false,
"results_due": false,
"sponsor_name": "Duke University",
"sponsor_slug": "duke-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06054230",
"publication_url": "https://clinicaltrials.gov/study/NCT06054230",
"title": "Genomic Sequencing for Evaluation of Fetal Structural Anomalies",
"has_exemption": false,
"start_date": "2023-09-18",
"completion_date": "2030-07-15",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, San Francisco",
"sponsor_slug": "university-of-california-san-francisco",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06678737",
"publication_url": "https://clinicaltrials.gov/study/NCT06678737",
"title": "CBIT+TMS R33 Phase",
"has_exemption": false,
"start_date": "2025-02-27",
"completion_date": "2030-07-15",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Minnesota",
"sponsor_slug": "university-of-minnesota",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07002216",
"publication_url": "https://clinicaltrials.gov/study/NCT07002216",
"title": "A Phase 2 Trial of Abbreviated Brentuximab Vedotin, Etoposide, Cyclophosphamide, Adriamycin, Dacarbazine, and Dexamethasone (BrECADD) Therapy in Stage 2 B-IV Hodgkin Lymphoma",
"has_exemption": false,
"start_date": "2025-07-15",
"completion_date": "2030-07-15",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Miami",
"sponsor_slug": "university-of-miami",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07220720",
"publication_url": "https://clinicaltrials.gov/study/NCT07220720",
"title": "Inclusion of POSLUMA® ((18)F-rhPSMA-7.3) PET-CT Imaging Improves Diagnostic Accuracy of Clinically-Significant Prostate Cancer Diagnosis in Men With PIRADS 2 and 3 Lesions on MRI",
"has_exemption": false,
"start_date": "2025-11-04",
"completion_date": "2030-07-15",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Florida",
"sponsor_slug": "university-of-florida",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06711887",
"publication_url": "https://clinicaltrials.gov/study/NCT06711887",
"title": "An Open-label Extension Study to Assess the Efficacy and Safety of Ianalumab With or Without Study Treatment Withdrawal in Adult Participants With Lupus Nephritis Who Have Completed Study Treatment in the CVAY736K12301 Core Study (SIRIUS-LN Extension)",
"has_exemption": false,
"start_date": "2025-05-19",
"completion_date": "2030-07-18",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06321601",
"publication_url": "https://clinicaltrials.gov/study/NCT06321601",
"title": "A Phase 3, Open-label, Uncontrolled Single-arm Study to Evaluate the Efficacy, Pharmacokinetics, and Safety of Avacopan in Combination With a Rituximab or a Cyclophosphamide-containing Regimen in Children From 6 Years to < 18 Years of Age With Active ANCA-associated Vasculitis (AAV)",
"has_exemption": false,
"start_date": "2024-10-22",
"completion_date": "2030-07-20",
"has_results": false,
"results_due": false,
"sponsor_name": "Amgen",
"sponsor_slug": "amgen",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06022939",
"publication_url": "https://clinicaltrials.gov/study/NCT06022939",
"title": "A Phase III, Randomized Study of Daratumumab, Cyclophosphamide, Bortezomib and Dexamethasone (Dara-VCD) Induction Followed by Autologous Stem Cell Transplant or Dara-VCD Consolidation and Daratumumab Maintenance in Patients With Newly Diagnosed AL Amyloidosis",
"has_exemption": false,
"start_date": "2024-07-01",
"completion_date": "2030-07-29",
"has_results": false,
"results_due": false,
"sponsor_name": "SWOG Cancer Research Network",
"sponsor_slug": "swog-cancer-research-network",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06561386",
"publication_url": "https://clinicaltrials.gov/study/NCT06561386",
"title": "A Phase 3, Randomized, Open-label Study of Nivolumab + Relatlimab Fixed-dose Combination With Chemotherapy Versus Pembrolizumab With Chemotherapy as First-line Treatment for Participants With Non-squamous (NSQ), Stage IV or Recurrent Non-small Cell Lung Cancer and With Tumor Cell PD-L1 Expression ≥ 1%",
"has_exemption": false,
"start_date": "2024-10-07",
"completion_date": "2030-07-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Bristol-Myers Squibb",
"sponsor_slug": "bristol-myers-squibb",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06731413",
"publication_url": "https://clinicaltrials.gov/study/NCT06731413",
"title": "Phase 2 Study to Evaluate Reduced Dose Chemotherapy in Combination With Anti-PD-1 Therapy as First Line Treatment in Vulnerable or Older Adults (Vulnerable or Age ≥70) With Advanced PD-L1 TPS <50% Non-small Cell Lung Cancer",
"has_exemption": false,
"start_date": "2025-02-11",
"completion_date": "2030-07-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Virginia Commonwealth University",
"sponsor_slug": "virginia-commonwealth-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06969755",
"publication_url": "https://clinicaltrials.gov/study/NCT06969755",
"title": "Biomarkers to Enhance Early Schizophrenia Treatment",
"has_exemption": false,
"start_date": "2025-07-30",
"completion_date": "2030-07-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Northwell Health",
"sponsor_slug": "northwell-health",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04373785",
"publication_url": "https://clinicaltrials.gov/study/NCT04373785",
"title": "A Multi-Center Pilot/Phase I and Phase II Clinical Trial of NG101m Adjuvant Therapy in Newly Diagnosed Glioblastoma Patients",
"has_exemption": false,
"start_date": "2027-01-01",
"completion_date": "2030-07-30",
"has_results": false,
"results_due": false,
"sponsor_name": "NeuGATE Theranostics",
"sponsor_slug": "neugate-theranostics",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06716866",
"publication_url": "https://clinicaltrials.gov/study/NCT06716866",
"title": "Temporally Interfering Electric Field Stimulation in the Treatment of Epilepsy - Effect of Temporal Interference on Biomarkers of Epilepsy",
"has_exemption": false,
"start_date": "2019-01-16",
"completion_date": "2030-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, Davis",
"sponsor_slug": "university-of-california-davis",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04188535",
"publication_url": "https://clinicaltrials.gov/study/NCT04188535",
"title": "RELAY: Repeated Magnetic Resonance Imaging Examinations to Analyze and Assess Your Cancer: A Prospective Study on the Use of Serial Magnetic Resonance Imaging in the Assessment of Changes During Treatment With Radiation Therapy",
"has_exemption": false,
"start_date": "2020-01-15",
"completion_date": "2030-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Dana-Farber Cancer Institute",
"sponsor_slug": "dana-farber-cancer-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04318717",
"publication_url": "https://clinicaltrials.gov/study/NCT04318717",
"title": "Adjuvant Pembrolizumab and Hypofractionated Radiation Therapy for the Treatment of Mucosal Melanoma",
"has_exemption": true,
"start_date": "2020-05-29",
"completion_date": "2030-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Washington University School of Medicine",
"sponsor_slug": "washington-university-school-of-medicine",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04743141",
"publication_url": "https://clinicaltrials.gov/study/NCT04743141",
"title": "Phase 3, Multicenter, Open-label Study to Assess the Long-term Safety and Tolerability of Rimegepant for the Acute Treatment of Migraine (With or Without Aura) in Children and Adolescents ≥ 6 to < 18 Years of Age",
"has_exemption": false,
"start_date": "2021-04-28",
"completion_date": "2030-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Pfizer",
"sponsor_slug": "pfizer",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05145127",
"publication_url": "https://clinicaltrials.gov/study/NCT05145127",
"title": "AN OPEN-LABEL EXTENSION STUDY TO EVALUATE THE LONG-TERM SAFETY, TOLERABILITY, AND EFFICACY OF MARSTACIMAB PROPHYLAXIS IN SEVERE (COAGULATION FACTOR ACTIVITY <1%) HEMOPHILIA A PARTICIPANTS WITH OR WITHOUT INHIBITORS OR MODERATELY SEVERE TO SEVERE HEMOPHILIA B PARTICIPANTS (COAGULATION FACTOR ACTIVITY ≤2%) WITH OR WITHOUT INHIBITORS",
"has_exemption": false,
"start_date": "2021-11-17",
"completion_date": "2030-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Pfizer",
"sponsor_slug": "pfizer",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05469893",
"publication_url": "https://clinicaltrials.gov/study/NCT05469893",
"title": "Immuno-PRISM (PRecision Intervention Smoldering Myeloma): A Randomized Phase II Platform Study of Select Immunotherapies for High-Risk Smoldering Myeloma",
"has_exemption": false,
"start_date": "2022-08-10",
"completion_date": "2030-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Irene Ghobrial, MD",
"sponsor_slug": "irene-ghobrial-md",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05768139",
"publication_url": "https://clinicaltrials.gov/study/NCT05768139",
"title": "First-in-Human Study of STX-478, a Mutant-Selective PI3Kα Inhibitor as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors",
"has_exemption": false,
"start_date": "2023-04-17",
"completion_date": "2030-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Eli Lilly and Company",
"sponsor_slug": "eli-lilly-and-company",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06072131",
"publication_url": "https://clinicaltrials.gov/study/NCT06072131",
"title": "A Phase 3, Randomized, Open-Label Study Comparing the Efficacy and Safety of the Combination of Beleodaq-CHOP or Folotyn-COP to the CHOP Regimen Alone in Newly Diagnosed Patients With Peripheral T-Cell Lymphoma",
"has_exemption": false,
"start_date": "2023-10-04",
"completion_date": "2030-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Acrotech Biopharma Inc.",
"sponsor_slug": "acrotech-biopharma-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05821855",
"publication_url": "https://clinicaltrials.gov/study/NCT05821855",
"title": "A Postmarketing Study Evaluating the Effectiveness and Safety of the XEN45 Glaucoma Treatment System in Subjects With Open-Angle Glaucoma in China",
"has_exemption": false,
"start_date": "2023-12-08",
"completion_date": "2030-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "AbbVie",
"sponsor_slug": "abbvie",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06461897",
"publication_url": "https://clinicaltrials.gov/study/NCT06461897",
"title": "A Phase 3, Open-label, Efficacy-Assessor-Blinded Study, Comparing the Safety and Efficacy of Upadacitinib to Dupilumab in Children From 2 to Less Than 12 Years of Age With Moderate to Severe Atopic Dermatitis",
"has_exemption": false,
"start_date": "2024-08-19",
"completion_date": "2030-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "AbbVie",
"sponsor_slug": "abbvie",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06577025",
"publication_url": "https://clinicaltrials.gov/study/NCT06577025",
"title": "A Phase 2, Open-label Study to Evaluate the Efficacy and Safety of Different Sequences of Ciltacabtagene Autoleucel (Cilta-cel), Talquetamab SC in Combination With Daratumumab SC (Tal-D) and Teclistamab SC in Combination With Daratumumab SC (Tec-D) Following Induction With Daratumumab, Bortezomib, Lenalidomide and Dexamethasone (DVRd) in Participants With Standard-risk Newly Diagnosed Multiple Myeloma",
"has_exemption": false,
"start_date": "2024-08-20",
"completion_date": "2030-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Janssen Research & Development, LLC",
"sponsor_slug": "janssen-research-development-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07007273",
"publication_url": "https://clinicaltrials.gov/study/NCT07007273",
"title": "Pembrolizumab for Advanced Cutaneous Sarcomas Not Including Angiosarcoma",
"has_exemption": false,
"start_date": "2025-06-20",
"completion_date": "2030-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "H. Lee Moffitt Cancer Center and Research Institute",
"sponsor_slug": "h-lee-moffitt-cancer-center-and-research-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06992440",
"publication_url": "https://clinicaltrials.gov/study/NCT06992440",
"title": "Empagliflozin to Improve Right Ventricular Function in Pulmonary Arterial Hypertension",
"has_exemption": false,
"start_date": "2025-06-26",
"completion_date": "2030-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Gustavo A Heresi, MD, MS",
"sponsor_slug": "gustavo-a-heresi-md-ms",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06950385",
"publication_url": "https://clinicaltrials.gov/study/NCT06950385",
"title": "A Phase 3, Multi-Site, Prospective, Randomized, Double-Blind, Placebo-Controlled Trial of eRapa to Improve Clinical Outcomes in Patients With Familial Adenomatous Polyposis",
"has_exemption": false,
"start_date": "2025-07-18",
"completion_date": "2030-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Rapamycin Holdings Inc.",
"sponsor_slug": "rapamycin-holdings-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07100106",
"publication_url": "https://clinicaltrials.gov/study/NCT07100106",
"title": "A Phase Ib/II Multicenter, Open-Label, Randomized Study Evaluating the Safety, Pharmacokinetics, and Activity of GDC-4198 Alone and in Combination With Giredestrant in Comparison With Abemaciclib and Giredestrant in Participants With Locally Advanced or Metastatic Estrogen Receptor-Positive, HER2-Negative Breast Cancer Who Have Previously Progressed During or After a CDK4/6 Inhibitor",
"has_exemption": false,
"start_date": "2025-10-07",
"completion_date": "2030-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Genentech, Inc.",
"sponsor_slug": "genentech-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07029529",
"publication_url": "https://clinicaltrials.gov/study/NCT07029529",
"title": "Phase 2 Dose-response Study of Apremilast in Women and Men With Alcohol Use Disorder",
"has_exemption": false,
"start_date": "2025-11-30",
"completion_date": "2030-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Yale University",
"sponsor_slug": "yale-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07101666",
"publication_url": "https://clinicaltrials.gov/study/NCT07101666",
"title": "Total Neoadjuvant Therapy With Short Course Radiation Therapy in Gastric Cancer",
"has_exemption": false,
"start_date": "2026-01-31",
"completion_date": "2030-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Washington University School of Medicine",
"sponsor_slug": "washington-university-school-of-medicine",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07137481",
"publication_url": "https://clinicaltrials.gov/study/NCT07137481",
"title": "Phase II Study of CD5 CAR Engineered IL15-transduced Cord Blood-derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Aggressive T Cell Hematological Malignancies",
"has_exemption": false,
"start_date": "2026-02-28",
"completion_date": "2030-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07227584",
"publication_url": "https://clinicaltrials.gov/study/NCT07227584",
"title": "Treatment of Newly Diagnosed Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia in Adolescents and Young Adults (AYAs)",
"has_exemption": false,
"start_date": "2026-04-30",
"completion_date": "2030-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Dana-Farber Cancer Institute",
"sponsor_slug": "dana-farber-cancer-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07225543",
"publication_url": "https://clinicaltrials.gov/study/NCT07225543",
"title": "Scavenging IsoLGs in Autoimmune Disease: a Proof-of-concept Clinical Study",
"has_exemption": false,
"start_date": "2026-05-15",
"completion_date": "2030-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Vanderbilt University Medical Center",
"sponsor_slug": "vanderbilt-university-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07211802",
"publication_url": "https://clinicaltrials.gov/study/NCT07211802",
"title": "Utilizing Continuous Ketone Monitors to Enable Safe Use of SGLT Inhibitors in Patients With Type 1 Diabetes",
"has_exemption": false,
"start_date": "2026-07-01",
"completion_date": "2030-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, San Diego",
"sponsor_slug": "university-of-california-san-diego",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07176546",
"publication_url": "https://clinicaltrials.gov/study/NCT07176546",
"title": "TAVNEOS for Otolaryngologic Manifestations of Granulomatosis With Polyangiitis",
"has_exemption": false,
"start_date": "2026-07-31",
"completion_date": "2030-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Robert Spiera, MD",
"sponsor_slug": "robert-spiera-md",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07261241",
"publication_url": "https://clinicaltrials.gov/study/NCT07261241",
"title": "NANT 2021-02: A Randomized Phase 2 Study of 131I-MIBG With Vorinostat VS. 131I-MIBG With Dinutuximab vs. 131I-MIBG With Dinutuximab and Vorinostat for Relapsed or Refractory Neuroblastoma",
"has_exemption": false,
"start_date": "2026-07-31",
"completion_date": "2030-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "New Approaches to Neuroblastoma Therapy Consortium",
"sponsor_slug": "new-approaches-to-neuroblastoma-therapy-consortium",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07215013",
"publication_url": "https://clinicaltrials.gov/study/NCT07215013",
"title": "Acoustic Resonance Therapy for Treatment of Empty Nose Syndrome: A Prospective, Phase 2 Randomized Clinical Trial",
"has_exemption": false,
"start_date": "2028-07-31",
"completion_date": "2030-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Stanford University",
"sponsor_slug": "stanford-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05737693",
"publication_url": "https://clinicaltrials.gov/study/NCT05737693",
"title": "Posttraumatic Stress Disorder (PTSD) Treatment: Using Ketamine to Enhance Memory Reconsolidation and Extinction of Overgeneralized Fear in Individuals Diagnosed With PTSD",
"has_exemption": false,
"start_date": "2023-08-21",
"completion_date": "2030-08-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Yale University",
"sponsor_slug": "yale-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06467344",
"publication_url": "https://clinicaltrials.gov/study/NCT06467344",
"title": "ACDN-01-001: Open-Label, Single Ascending Dose Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of Subretinal ACDN-01 in Participants With ABCA4-related Retinopathy",
"has_exemption": false,
"start_date": "2024-06-11",
"completion_date": "2030-08-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Ascidian Therapeutics, Inc",
"sponsor_slug": "ascidian-therapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06843551",
"publication_url": "https://clinicaltrials.gov/study/NCT06843551",
"title": "A Phase 2 Single Arm Trial of Stereotactic Body Radiation Therapy Followed by Dual Immune Checkpoint Inhibition for Patients With Metastatic Pancreatic Ductal Adenocarcinoma - The Miami \"EMPIRE\" Trial - Eradication of Metastatic Pancreatic Cancer With Immuno-Radiation",
"has_exemption": false,
"start_date": "2025-06-18",
"completion_date": "2030-08-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Benjamin Spieler",
"sponsor_slug": "benjamin-spieler",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06976840",
"publication_url": "https://clinicaltrials.gov/study/NCT06976840",
"title": "Rapid Antidepressant Dynamics in Acute Neuromodulation Treatments",
"has_exemption": false,
"start_date": "2026-01-01",
"completion_date": "2030-08-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Marta Peciña MD PhD",
"sponsor_slug": "marta-pecina-md-phd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04976322",
"publication_url": "https://clinicaltrials.gov/study/NCT04976322",
"title": "A Multicenter, Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of Dapirolizumab Pegol Treatment in Study Participants With Systemic Lupus Erythematosus",
"has_exemption": false,
"start_date": "2021-07-27",
"completion_date": "2030-08-07",
"has_results": false,
"results_due": false,
"sponsor_name": "UCB Biopharma SRL",
"sponsor_slug": "ucb-biopharma-srl",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04300556",
"publication_url": "https://clinicaltrials.gov/study/NCT04300556",
"title": "A Multicenter, Open-Label Phase 1/2 Trial Evaluating the Safety, Tolerability, and Efficacy of MORAb-202, a Folate Receptor Alpha (FRα)-Targeting Antibody-drug Conjugate (ADC) in Subjects With Selected Tumor Types",
"has_exemption": false,
"start_date": "2020-08-06",
"completion_date": "2030-08-08",
"has_results": false,
"results_due": false,
"sponsor_name": "Eisai Inc.",
"sponsor_slug": "eisai-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04579224",
"publication_url": "https://clinicaltrials.gov/study/NCT04579224",
"title": "A Phase III Randomized Trial of Eribulin (NSC #707389) With Gemcitabine Versus Standard of Care (Physician's Choice) for Treatment of Metastatic Urothelial Carcinoma Refractory to, or Ineligible for, Anti PD1/PDL1 Therapy",
"has_exemption": false,
"start_date": "2021-06-28",
"completion_date": "2030-08-15",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06971939",
"publication_url": "https://clinicaltrials.gov/study/NCT06971939",
"title": "A Phase 4, Multicenter, Open-label Study to Evaluate Long-term Safety and Efficacy of Revakinagene Taroretcel-Lwey (NT-501) Previously Implanted During a Phase 1, Phase 2, or Phase 3 Clinical Study and to Evaluate NT-501 Implanted in Participants Who Underwent the Sham Procedure in a Phase 3 Clinical Study of Macular Telangiectasia Type 2 (MacTel)",
"has_exemption": false,
"start_date": "2025-08-15",
"completion_date": "2030-08-15",
"has_results": false,
"results_due": false,
"sponsor_name": "Neurotech Pharmaceuticals",
"sponsor_slug": "neurotech-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06651970",
"publication_url": "https://clinicaltrials.gov/study/NCT06651970",
"title": "A Multicentre, Open-label, Randomised Phase IV Study to Investigate Acalabrutinib Monotherapy Compared to Investigator's Choice of Treatment in Adults (> 18 Years) With Chronic Lymphocytic Leukaemia and Moderate to Severe Cardiac Impairment",
"has_exemption": false,
"start_date": "2025-02-04",
"completion_date": "2030-08-16",
"has_results": false,
"results_due": false,
"sponsor_name": "AstraZeneca",
"sponsor_slug": "astrazeneca",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06683755",
"publication_url": "https://clinicaltrials.gov/study/NCT06683755",
"title": "Phase I/IIa Dose Finding Study of Triplet Regimen of Relatlimab Ipilimumab and NIvolumab in First Line Therapy of Metastatic Melanoma (TRINITY)",
"has_exemption": false,
"start_date": "2025-05-01",
"completion_date": "2030-08-16",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT02316379",
"publication_url": "https://clinicaltrials.gov/study/NCT02316379",
"title": "Use of Hyperpolarized 129Xe MR Lung Imaging in Adults for Calibration",
"has_exemption": false,
"start_date": "2015-02-28",
"completion_date": "2030-08-24",
"has_results": false,
"results_due": false,
"sponsor_name": "Children's Hospital Medical Center, Cincinnati",
"sponsor_slug": "childrens-hospital-medical-center-cincinnati",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT05983276",
"publication_url": "https://clinicaltrials.gov/study/NCT05983276",
"title": "Combination of the Hypomethylating Agent Decitabine and the Nuclear Export Receptor XPO-1 Inhibitor Selinexor to Reverse Platinum Resistance in Relapsed/Refractory Epithelial Ovarian Cancer",
"has_exemption": false,
"start_date": "2023-11-16",
"completion_date": "2030-08-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Loyola University",
"sponsor_slug": "loyola-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04877522",
"publication_url": "https://clinicaltrials.gov/study/NCT04877522",
"title": "An Open Label, Multi-center Asciminib Roll-over Study to Assess Long-term Safety in Patients Who Have Completed a Novartis Sponsored Asciminib Study and Are Judged by the Investigator to Benefit From Continued Treatment",
"has_exemption": false,
"start_date": "2022-08-30",
"completion_date": "2030-08-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05451004",
"publication_url": "https://clinicaltrials.gov/study/NCT05451004",
"title": "SPECT-CT Guided ELEctive Contralateral Neck Treatment for Patients With Lateralized Oropharyngeal Cancer. A Phase III Randomized Controlled Trial",
"has_exemption": false,
"start_date": "2023-02-10",
"completion_date": "2030-08-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Canadian Cancer Trials Group",
"sponsor_slug": "canadian-cancer-trials-group",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07154706",
"publication_url": "https://clinicaltrials.gov/study/NCT07154706",
"title": "A Phase 3 Multicenter Double-blind Randomized Study of Taletrectinib Versus Placebo in Patients With ROS1-Fusion Positive Stage IB-IIIA Non-Small Cell Lung Cancer Who Have Undergone Complete Tumor Resection",
"has_exemption": false,
"start_date": "2025-08-21",
"completion_date": "2030-08-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Nuvation Bio, Inc.",
"sponsor_slug": "nuvation-bio-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07039422",
"publication_url": "https://clinicaltrials.gov/study/NCT07039422",
"title": "Exploratory Study of Ianalumab in Adults With Primary Immune Thrombocytopenia (ITP) and Warm-antibody Autoimmune Hemolytic Anemia (wAIHA) Who Have Previously Benefited From Ianalumab (VAY RE-HIT)",
"has_exemption": false,
"start_date": "2025-10-03",
"completion_date": "2030-08-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07079111",
"publication_url": "https://clinicaltrials.gov/study/NCT07079111",
"title": "3D Printed Occlusal Splints for Intraoperative Use",
"has_exemption": false,
"start_date": "2026-01-30",
"completion_date": "2030-08-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Johns Hopkins University",
"sponsor_slug": "johns-hopkins-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03396276",
"publication_url": "https://clinicaltrials.gov/study/NCT03396276",
"title": "Houston Emergency Opioid Engagement System (HEROES)",
"has_exemption": false,
"start_date": "2018-04-01",
"completion_date": "2030-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "The University of Texas Health Science Center, Houston",
"sponsor_slug": "the-university-of-texas-health-science-center-houston",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04811014",
"publication_url": "https://clinicaltrials.gov/study/NCT04811014",
"title": "Houston Emergency Engagement System for Youths and Adolescents",
"has_exemption": false,
"start_date": "2021-04-19",
"completion_date": "2030-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "The University of Texas Health Science Center, Houston",
"sponsor_slug": "the-university-of-texas-health-science-center-houston",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06051617",
"publication_url": "https://clinicaltrials.gov/study/NCT06051617",
"title": "AFFIRM: A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effect of Seladelpar on Clinical Outcomes in Patients With Primary Biliary Cholangitis (PBC) and Compensated Cirrhosis",
"has_exemption": false,
"start_date": "2023-09-07",
"completion_date": "2030-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Gilead Sciences",
"sponsor_slug": "gilead-sciences",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07008469",
"publication_url": "https://clinicaltrials.gov/study/NCT07008469",
"title": "A Global Phase 3 Open-Label Extension Study to Assess the Long-Term Safety, Tolerability, and Efficacy of Intravenous AOC 1001 for the Treatment of Myotonic Dystrophy Type 1",
"has_exemption": false,
"start_date": "2025-07-25",
"completion_date": "2030-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Avidity Biosciences, Inc.",
"sponsor_slug": "avidity-biosciences-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07219485",
"publication_url": "https://clinicaltrials.gov/study/NCT07219485",
"title": "An Open-Label Study to Evaluate Safety of Pitolisant in Participants With Prader-Willi Syndrome",
"has_exemption": false,
"start_date": "2025-08-20",
"completion_date": "2030-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Harmony Biosciences Management, Inc.",
"sponsor_slug": "harmony-biosciences-management-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06948019",
"publication_url": "https://clinicaltrials.gov/study/NCT06948019",
"title": "Safety and Efficacy of AAV9/AP4B1 For Patients With AP4B1-related Hereditary Spastic Paraplegia Type 47 (SPG47): A Phase 1/2 Single-Center, Open-Label Study of Stereotactic Intra-cisterna Magna Administration",
"has_exemption": false,
"start_date": "2025-08-31",
"completion_date": "2030-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "BlackfinBio Ltd",
"sponsor_slug": "blackfinbio-ltd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07022405",
"publication_url": "https://clinicaltrials.gov/study/NCT07022405",
"title": "Stratified Pharmacological Approaches for Regulating Circuit-Level Effects Study",
"has_exemption": false,
"start_date": "2025-08-31",
"completion_date": "2030-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Stanford University",
"sponsor_slug": "stanford-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07185256",
"publication_url": "https://clinicaltrials.gov/study/NCT07185256",
"title": "A Phase 1b/2a, Open-Label, Dose-Exploration Basket Study to Investigate the Safety and Tolerability of Subretinally Injected OPGx-BEST1 Administered in Patients With Either Autosomal-Dominant BEST1 Disease (Best Vitelliform Macular Dystrophy [BVMD]) or Autosomal-Recessive Bestrophinopathy (ARB)",
"has_exemption": false,
"start_date": "2025-09-30",
"completion_date": "2030-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Opus Genetics, Inc",
"sponsor_slug": "opus-genetics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07165028",
"publication_url": "https://clinicaltrials.gov/study/NCT07165028",
"title": "A Master Protocol for a Randomized, Controlled, Clinical Trial of Multiple Pharmacologic Agents in Adult Participants With Metabolic Dysfunction-Associated Steatotic Liver Disease Who Are at Increased Risk of Developing Major Adverse Liver Outcomes",
"has_exemption": false,
"start_date": "2025-10-15",
"completion_date": "2030-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Eli Lilly and Company",
"sponsor_slug": "eli-lilly-and-company",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07227779",
"publication_url": "https://clinicaltrials.gov/study/NCT07227779",
"title": "A PHASE 2 NOVEL ANTIMICROBIAL COMBINATION THERAPY TO TREAT TUBERCULOUS MENINGITIS",
"has_exemption": false,
"start_date": "2026-02-15",
"completion_date": "2030-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Minnesota",
"sponsor_slug": "university-of-minnesota",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06841679",
"publication_url": "https://clinicaltrials.gov/study/NCT06841679",
"title": "A Multi-national, Open-label, Randomized Phase II/III Clinical Study of Utidelone Capsule (UTD2) Combined With Fluoropyrimidine- and Platinum-containing Therapy in First-line Treatment of Patients With Locally Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma",
"has_exemption": false,
"start_date": "2025-08-28",
"completion_date": "2030-09-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Beijing Biostar Pharmaceuticals Co., Ltd.",
"sponsor_slug": "beijing-biostar-pharmaceuticals-co-ltd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07164131",
"publication_url": "https://clinicaltrials.gov/study/NCT07164131",
"title": "Azithromycin Versus Doxycycline in Hospitalized Adult Patients With Community Acquired Pneumonia Treated With Beta-lactams",
"has_exemption": false,
"start_date": "2025-09-15",
"completion_date": "2030-09-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Mayo Clinic",
"sponsor_slug": "mayo-clinic",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06827990",
"publication_url": "https://clinicaltrials.gov/study/NCT06827990",
"title": "Evaluation of the GORE® Ascending Stent Graft in the Treatment of De Novo Type A Aortic Dissections",
"has_exemption": false,
"start_date": "2025-09-22",
"completion_date": "2030-09-01",
"has_results": false,
"results_due": false,
"sponsor_name": "W.L.Gore & Associates",
"sponsor_slug": "wlgore-associates",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07153003",
"publication_url": "https://clinicaltrials.gov/study/NCT07153003",
"title": "Efficacy And Safety Of Tramadol And Oxycodone Versus Oxycodone Monotherapy For Pain Control After Primary Total Knee And Total Hip Arthroplasty: A Prospective Randomized Controlled Trial",
"has_exemption": false,
"start_date": "2025-12-01",
"completion_date": "2030-09-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Mayo Clinic",
"sponsor_slug": "mayo-clinic",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07223567",
"publication_url": "https://clinicaltrials.gov/study/NCT07223567",
"title": "Phase II Trial of Regorafenib Plus Lorigerlimab in Patients With Locally Recurrent or Regrowing pMMR/MSS Localized Rectal Cancer",
"has_exemption": false,
"start_date": "2026-04-30",
"completion_date": "2030-09-01",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07228624",
"publication_url": "https://clinicaltrials.gov/study/NCT07228624",
"title": "Expanding Use of Peri-Hematopoietic Cell Transplantation Ruxolitinib to Patients of Advanced Age With Myelofibrosis and Myelodysplastic Syndrome/Myeloproliferative Neoplasm Overlap Syndromes",
"has_exemption": false,
"start_date": "2026-05-01",
"completion_date": "2030-09-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Fred Hutchinson Cancer Center",
"sponsor_slug": "fred-hutchinson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06794944",
"publication_url": "https://clinicaltrials.gov/study/NCT06794944",
"title": "Use of Fidaxomicin Compared to Vancomycin for Decolonization of C. Difficile in Patients With Inflammatory Bowel Disease",
"has_exemption": false,
"start_date": "2026-09-30",
"completion_date": "2030-09-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Brigham and Women's Hospital",
"sponsor_slug": "brigham-and-womens-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05987241",
"publication_url": "https://clinicaltrials.gov/study/NCT05987241",
"title": "MODERN: An Integrated Phase 2/3 and Phase 3 Trial of MRD-Based Optimization of ADjuvant ThErapy in URothelial CaNcer",
"has_exemption": false,
"start_date": "2024-02-02",
"completion_date": "2030-09-02",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06784752",
"publication_url": "https://clinicaltrials.gov/study/NCT06784752",
"title": "A Phase III Multi-center, Randomized, Open-label Study to Evaluate the Efficacy and Safety of [177Lu]Lu-DOTA-TATE in Patients Newly Diagnosed With Grade 1 and Grade 2 (Ki-67 <10%) Advanced GEP-NET With High Disease Burden (NETTER-3)",
"has_exemption": false,
"start_date": "2025-05-30",
"completion_date": "2030-09-27",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT02559778",
"publication_url": "https://clinicaltrials.gov/study/NCT02559778",
"title": "A Study Using Molecular Guided Therapy With Induction Chemotherapy Followed by a Randomized Controlled Trial of Standard Immunotherapy With or Without DFMO Followed by DFMO Maintenance for Subjects With Newly Diagnosed High-Risk Neuroblastoma",
"has_exemption": false,
"start_date": "2015-09-30",
"completion_date": "2030-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Giselle Sholler",
"sponsor_slug": "giselle-sholler",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT03143374",
"publication_url": "https://clinicaltrials.gov/study/NCT03143374",
"title": "Positron Emission Tomography (PET) Imaging of Tau Pathology in Neurodegenerative Disease",
"has_exemption": false,
"start_date": "2016-08-23",
"completion_date": "2030-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Pennsylvania",
"sponsor_slug": "university-of-pennsylvania",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT03424005",
"publication_url": "https://clinicaltrials.gov/study/NCT03424005",
"title": "A Phase Ib/II, Open-label, Multicenter, Randomized Umbrella Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Patients With Metastatic Breast Cancer (Morpheus-panBC)",
"has_exemption": false,
"start_date": "2018-03-30",
"completion_date": "2030-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Hoffmann-La Roche",
"sponsor_slug": "hoffmann-la-roche",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03126916",
"publication_url": "https://clinicaltrials.gov/study/NCT03126916",
"title": "A Phase 3 Study of 131I-Metaiodobenzylguanidine (131I-MIBG) or ALK Inhibitor Therapy Added to Intensive Therapy for Children With Newly Diagnosed High-Risk Neuroblastoma (NBL)",
"has_exemption": false,
"start_date": "2018-05-14",
"completion_date": "2030-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Children's Oncology Group",
"sponsor_slug": "childrens-oncology-group",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04584853",
"publication_url": "https://clinicaltrials.gov/study/NCT04584853",
"title": "PreOperative Endocrine Therapy for Individualised Care With Abemaciclib",
"has_exemption": false,
"start_date": "2020-12-23",
"completion_date": "2030-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Institute of Cancer Research, United Kingdom",
"sponsor_slug": "institute-of-cancer-research-united-kingdom",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04685616",
"publication_url": "https://clinicaltrials.gov/study/NCT04685616",
"title": "A Randomised Phase III Trial With a PET Response Adapted Design Comparing ABVD +/- ISRT With A2VD +/- ISRT in Patients With Previously Untreated Stage IA/IIA Hodgkin Lymphoma",
"has_exemption": false,
"start_date": "2022-04-14",
"completion_date": "2030-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University College, London",
"sponsor_slug": "university-college-london",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06109272",
"publication_url": "https://clinicaltrials.gov/study/NCT06109272",
"title": "A Phase 2/3, Randomized Study to Evaluate the Dose Optimization, Safety, and Efficacy of Livmoniplimab in Combination With Budigalimab in Subjects With Locally Advanced or Metastatic Hepatocellular Carcinoma (HCC) Who Have Not Previously Received Systemic Treatment",
"has_exemption": false,
"start_date": "2024-01-11",
"completion_date": "2030-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "AbbVie",
"sponsor_slug": "abbvie",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06441955",
"publication_url": "https://clinicaltrials.gov/study/NCT06441955",
"title": "Covid-19 Long Haul Syndrome: Undiagnosed Disorder Post Covid-19 Alternative Treatment Study.",
"has_exemption": false,
"start_date": "2024-03-01",
"completion_date": "2030-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Well- Konnect Healthcare Services and Research Firm",
"sponsor_slug": "well-konnect-healthcare-services-and-research-firm",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05673018",
"publication_url": "https://clinicaltrials.gov/study/NCT05673018",
"title": "REACH Study: Galleri® in the Medicare Population.",
"has_exemption": false,
"start_date": "2024-07-12",
"completion_date": "2030-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "GRAIL, Inc.",
"sponsor_slug": "grail-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06475989",
"publication_url": "https://clinicaltrials.gov/study/NCT06475989",
"title": "A Randomized Phase III Study of BRAF-Targeted Therapy vs Cabozantinib in RAI-Refractory Differentiated Thyroid Cancer With BRAF V600Em",
"has_exemption": false,
"start_date": "2024-08-22",
"completion_date": "2030-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "ECOG-ACRIN Cancer Research Group",
"sponsor_slug": "ecog-acrin-cancer-research-group",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06518785",
"publication_url": "https://clinicaltrials.gov/study/NCT06518785",
"title": "Ultrasound Neuromodulation of the Brain for Alcohol Use Disorder",
"has_exemption": false,
"start_date": "2025-01-07",
"completion_date": "2030-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, San Francisco",
"sponsor_slug": "university-of-california-san-francisco",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06861244",
"publication_url": "https://clinicaltrials.gov/study/NCT06861244",
"title": "PNOC031: Protocol for Embryonal Tumor With Multilayered Rosettes (ETMR)",
"has_exemption": false,
"start_date": "2025-03-06",
"completion_date": "2030-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, San Francisco",
"sponsor_slug": "university-of-california-san-francisco",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06953882",
"publication_url": "https://clinicaltrials.gov/study/NCT06953882",
"title": "SELECT: A Phase II Adjuvant Trial Evaluating the Impact of Omitting Chemotherapy Based on Patient's Selection for Moderate to High-Anatomical Risk, Low-Genomic Risk, ER-Positive, HER2- Negative Breast Cancer With a Combination Regimen of Ribociclib and Optimized Endocrine Therapy",
"has_exemption": false,
"start_date": "2025-07-09",
"completion_date": "2030-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Yale University",
"sponsor_slug": "yale-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06941857",
"publication_url": "https://clinicaltrials.gov/study/NCT06941857",
"title": "A Phase 2 Study of NC410 and FOLFIRINOX in Combination With Nivolumab With or Without Ipilimumab in Patients With Treatment-naïve, Metastatic Pancreatic Cancer",
"has_exemption": false,
"start_date": "2025-09-04",
"completion_date": "2030-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins",
"sponsor_slug": "sidney-kimmel-comprehensive-cancer-center-at-johns-hopkins",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07096362",
"publication_url": "https://clinicaltrials.gov/study/NCT07096362",
"title": "A Phase 2 Study Assessing Utility of ctDNA in Early Switch of First-line mFOLFIRINOX in Metastatic Pancreatic Ductal Adenocarcinoma",
"has_exemption": false,
"start_date": "2025-09-09",
"completion_date": "2030-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Miami",
"sponsor_slug": "university-of-miami",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06997081",
"publication_url": "https://clinicaltrials.gov/study/NCT06997081",
"title": "Elranatamab, Lenalidomide, Dexamethasone in Newly Diagnosed Multiple Myeloma, a Clinical and Correlative Phase 2 Study",
"has_exemption": false,
"start_date": "2025-09-16",
"completion_date": "2030-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Miami",
"sponsor_slug": "university-of-miami",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07158476",
"publication_url": "https://clinicaltrials.gov/study/NCT07158476",
"title": "Efficacy of Methylprednisolone for Pain Control After ACL Repair: A Randomized Controlled Trial",
"has_exemption": false,
"start_date": "2025-10-21",
"completion_date": "2030-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "St. Louis University",
"sponsor_slug": "st-louis-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07221539",
"publication_url": "https://clinicaltrials.gov/study/NCT07221539",
"title": "Restoration of Consciousness With Ultrasonic Deep Brain Stimulation During Anesthetic Sedation",
"has_exemption": false,
"start_date": "2025-10-24",
"completion_date": "2030-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Michigan",
"sponsor_slug": "university-of-michigan",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07214207",
"publication_url": "https://clinicaltrials.gov/study/NCT07214207",
"title": "Orexin Receptor Antagonism for the Treatment of Alcohol Use Disorder and Stress-Related Drinking",
"has_exemption": false,
"start_date": "2025-11-30",
"completion_date": "2030-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Ohio State University",
"sponsor_slug": "ohio-state-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06966362",
"publication_url": "https://clinicaltrials.gov/study/NCT06966362",
"title": "Varenicline for Smoking Reduction in Veterans Unwilling to Quit",
"has_exemption": false,
"start_date": "2025-12-01",
"completion_date": "2030-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "VA Office of Research and Development",
"sponsor_slug": "va-office-of-research-and-development",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07225985",
"publication_url": "https://clinicaltrials.gov/study/NCT07225985",
"title": "Salvage Treatment With Bendamustine and Pralatrexate Followed Immediately by Reduced-Intensity Conditioning (RIC) Allogeneic Hematopoietic Cell Transplantation (Prala-Benda/RIC) for Adults With T Cell Lymphomas: A Phase 1/2 Study",
"has_exemption": false,
"start_date": "2026-05-01",
"completion_date": "2030-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Fred Hutchinson Cancer Center",
"sponsor_slug": "fred-hutchinson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06034821",
"publication_url": "https://clinicaltrials.gov/study/NCT06034821",
"title": "Rapid Reversal of Suicidal Depression: Comparative Effectiveness of ECT vs. KETAMINE Over the Lifespan (REaKT-SD)",
"has_exemption": false,
"start_date": "2023-10-01",
"completion_date": "2030-10-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Brigham and Women's Hospital",
"sponsor_slug": "brigham-and-womens-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07240922",
"publication_url": "https://clinicaltrials.gov/study/NCT07240922",
"title": "The Dynamics of the Immune Responses to Repeat Influenza Vaccination Exposures (DRIVE III) Study - a Randomized Controlled Trial",
"has_exemption": false,
"start_date": "2025-10-01",
"completion_date": "2030-10-01",
"has_results": false,
"results_due": false,
"sponsor_name": "The University of Hong Kong",
"sponsor_slug": "the-university-of-hong-kong",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06942442",
"publication_url": "https://clinicaltrials.gov/study/NCT06942442",
"title": "A Phase II Trial of Tebentafusp in HLA-A*02:01 Positive Patients With Advanced Clear Cell Sarcoma",
"has_exemption": false,
"start_date": "2025-10-22",
"completion_date": "2030-10-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Sarcoma Alliance for Research through Collaboration",
"sponsor_slug": "sarcoma-alliance-for-research-through-collaboration",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07075510",
"publication_url": "https://clinicaltrials.gov/study/NCT07075510",
"title": "A Phase I/II Study of Subcutaneous Daratumumab Administration in the Anterior Upper Thigh Vs Abdomen in Patients With Plasma Cell Disorders",
"has_exemption": false,
"start_date": "2025-10-23",
"completion_date": "2030-10-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Maryland, Baltimore",
"sponsor_slug": "university-of-maryland-baltimore",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07209189",
"publication_url": "https://clinicaltrials.gov/study/NCT07209189",
"title": "Neoadjuvant Chemotherapy and PD-1 Inhibition for Head and Neck Cancer Treatment De-escalation (NeoScorch HN)",
"has_exemption": false,
"start_date": "2025-12-01",
"completion_date": "2030-10-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins",
"sponsor_slug": "sidney-kimmel-comprehensive-cancer-center-at-johns-hopkins",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06926595",
"publication_url": "https://clinicaltrials.gov/study/NCT06926595",
"title": "Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) With Low-Dose Post-Transplant Cyclophosphamide for Prophylaxis of Graft-versus-Host Disease in Hematological Malignancies",
"has_exemption": false,
"start_date": "2026-02-01",
"completion_date": "2030-10-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Milton S. Hershey Medical Center",
"sponsor_slug": "milton-s-hershey-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05487599",
"publication_url": "https://clinicaltrials.gov/study/NCT05487599",
"title": "An Open-label, Dose-Finding, Phase 1/2 Study to Evaluate the Safety and Tolerability of a Single Intravenous Dose of LY3884961 in Patients With Peripheral Manifestations of Gaucher Disease (PROCEED)",
"has_exemption": false,
"start_date": "2022-12-20",
"completion_date": "2030-10-02",
"has_results": false,
"results_due": false,
"sponsor_name": "Prevail Therapeutics",
"sponsor_slug": "prevail-therapeutics",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07098364",
"publication_url": "https://clinicaltrials.gov/study/NCT07098364",
"title": "A Phase 1/2 Open-Label Study Evaluating the Safety and Efficacy of ST-067 in Combination With CD19-Directed CAR T-Cell Therapy in Patients With Relapsed/Refractory (R/R) Large B-Cell Lymphoma (LBCL)",
"has_exemption": false,
"start_date": "2025-12-01",
"completion_date": "2030-10-04",
"has_results": false,
"results_due": false,
"sponsor_name": "Fred Hutchinson Cancer Center",
"sponsor_slug": "fred-hutchinson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07192237",
"publication_url": "https://clinicaltrials.gov/study/NCT07192237",
"title": "Phase 2 Study to Assess the Safety and Efficacy of Subcutaneous Blinatumomab in Patients With Measurable Residual Disease Positive B-cell Acute Lymphoblastic Leukemia",
"has_exemption": false,
"start_date": "2026-02-27",
"completion_date": "2030-10-12",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04270409",
"publication_url": "https://clinicaltrials.gov/study/NCT04270409",
"title": "A Phase 3 Randomized, Open-label, Multicenter Study of Isatuximab (SAR650984) in Combination With Lenalidomide and Dexamethasone Versus Lenalidomide and Dexamethasone in Patients With High-risk Smoldering Multiple Myeloma",
"has_exemption": false,
"start_date": "2020-06-16",
"completion_date": "2030-10-14",
"has_results": false,
"results_due": false,
"sponsor_name": "Sanofi",
"sponsor_slug": "sanofi",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04246086",
"publication_url": "https://clinicaltrials.gov/study/NCT04246086",
"title": "A Phase Ib/II, Open-Label, Multicenter Study With a Non-Randomized Stage Evaluating the Safety, Pharmacokinetics, and Efficacy of Mosunetuzumab Plus Lenalidomide (+Len), and a Randomized Stage Evaluating the Safety, Tolerability, and Pharmacokinetics of SC Versus IV Mosunetuzumab + Len in Patients With Follicular Lymphoma",
"has_exemption": false,
"start_date": "2020-08-12",
"completion_date": "2030-10-15",
"has_results": false,
"results_due": false,
"sponsor_name": "Hoffmann-La Roche",
"sponsor_slug": "hoffmann-la-roche",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06525766",
"publication_url": "https://clinicaltrials.gov/study/NCT06525766",
"title": "Single Arm Pilot Trial of Adaptive Therapy (AT) With Capecitabine for the Treatment of Metastatic Estrogen Receptor Positive, Hormone Refractory Breast Cancer",
"has_exemption": false,
"start_date": "2025-10-01",
"completion_date": "2030-10-15",
"has_results": false,
"results_due": false,
"sponsor_name": "Mayo Clinic",
"sponsor_slug": "mayo-clinic",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04725110",
"publication_url": "https://clinicaltrials.gov/study/NCT04725110",
"title": "Phase II Trial of Direct Topical Lung T3 Treatment to Improve Outcome & Sequelae of COVID-19 ARDS - A Multi-Site, Randomized, Double-blinded, Placebo-Controlled Clinical Trial",
"has_exemption": false,
"start_date": "2026-01-15",
"completion_date": "2030-10-15",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Minnesota",
"sponsor_slug": "university-of-minnesota",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03516617",
"publication_url": "https://clinicaltrials.gov/study/NCT03516617",
"title": "Randomized Phase 2 Study Comparing Acalabrutinib to Acalabrutinib and Obinutuzumab in the Treatment of Patients With Early-Stage Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) Who Are at High Risk of Disease Progression",
"has_exemption": false,
"start_date": "2018-09-10",
"completion_date": "2030-10-16",
"has_results": false,
"results_due": false,
"sponsor_name": "Mayo Clinic",
"sponsor_slug": "mayo-clinic",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07232602",
"publication_url": "https://clinicaltrials.gov/study/NCT07232602",
"title": "A Phase 1/2 Open-Label Rolling-Arm Umbrella Platform Study of Investigational Agents in Combination With Enfortumab Vedotin Plus Pembrolizumab as First-Line Treatment in Participants With Locally Advanced or Metastatic Urothelial Carcinoma: KEYMAKER-U04-Substudy 04D",
"has_exemption": false,
"start_date": "2025-12-15",
"completion_date": "2030-10-18",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06669117",
"publication_url": "https://clinicaltrials.gov/study/NCT06669117",
"title": "A First-In-Human (FIH) Phase I/II Open-label, Multicentre, Dose Escalation and Expansion Trial of VERT-002 in Patients With Locally Advanced or Metastatic Solid Tumors Including Non-small Cell Lung Cancer (NSCLC) Harboring Mesenchymal-Epithelial Transition (MET) Alterations",
"has_exemption": false,
"start_date": "2024-10-22",
"completion_date": "2030-10-21",
"has_results": false,
"results_due": false,
"sponsor_name": "Pierre Fabre Medicament",
"sponsor_slug": "pierre-fabre-medicament",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04545957",
"publication_url": "https://clinicaltrials.gov/study/NCT04545957",
"title": "Judging MR Simulation Procedures: A Phase I-II Study of the Use of Magnetic Resonance Imaging Simulation in the Planning of Radiation Treatments",
"has_exemption": false,
"start_date": "2020-10-14",
"completion_date": "2030-10-22",
"has_results": false,
"results_due": false,
"sponsor_name": "Brigham and Women's Hospital",
"sponsor_slug": "brigham-and-womens-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06646289",
"publication_url": "https://clinicaltrials.gov/study/NCT06646289",
"title": "An Open-label, Multicenter, Phase 2 Follow-on Study for Second Eye Treatment of Patients Previously Treated With a Recombinant Adeno-associated Virus Vector (AAV5 hRKp.RPGR) for Gene Therapy of Adults and Children With X-linked Retinitis Pigmentosa Owing to Defects in Retinitis Pigmentosa GTPase Regulator (RPGR)",
"has_exemption": false,
"start_date": "2024-10-10",
"completion_date": "2030-10-24",
"has_results": false,
"results_due": false,
"sponsor_name": "Janssen Research & Development, LLC",
"sponsor_slug": "janssen-research-development-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07181109",
"publication_url": "https://clinicaltrials.gov/study/NCT07181109",
"title": "ZENITH: A Phase 3 Global, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Zilebesiran in Addition to Standard of Care in Reducing Major Adverse Cardiovascular Events in Adult Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease",
"has_exemption": false,
"start_date": "2025-09-22",
"completion_date": "2030-10-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Alnylam Pharmaceuticals",
"sponsor_slug": "alnylam-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07222956",
"publication_url": "https://clinicaltrials.gov/study/NCT07222956",
"title": "An Open-label, Single-center Study of Remibrutinib Using Ultra High-field (7T) MR Imaging in Relapsing or Progressive MS (RemiSeven)",
"has_exemption": false,
"start_date": "2026-04-01",
"completion_date": "2030-10-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Moein Amin",
"sponsor_slug": "moein-amin",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04062266",
"publication_url": "https://clinicaltrials.gov/study/NCT04062266",
"title": "Phase II Study of 5-Azacytidine (AZA) + Venetoclax as Maintenance Therapy in Patients With AML in Remission",
"has_exemption": false,
"start_date": "2019-09-13",
"completion_date": "2030-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04948619",
"publication_url": "https://clinicaltrials.gov/study/NCT04948619",
"title": "Immune Function and Response to Vaccination Following Completion of Cancer Directed Systemic Therapy in Pediatric Patients With Cancer",
"has_exemption": false,
"start_date": "2022-08-08",
"completion_date": "2030-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Wake Forest University Health Sciences",
"sponsor_slug": "wake-forest-university-health-sciences",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05371093",
"publication_url": "https://clinicaltrials.gov/study/NCT05371093",
"title": "A Phase 3 Randomized, Open-Label, Multicenter Study Evaluating the Efficacy of Axicabtagene Ciloleucel Versus Standard of Care Therapy in Subjects With Relapsed/Refractory Follicular Lymphoma",
"has_exemption": false,
"start_date": "2022-09-22",
"completion_date": "2030-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Kite, A Gilead Company",
"sponsor_slug": "kite-a-gilead-company",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07142408",
"publication_url": "https://clinicaltrials.gov/study/NCT07142408",
"title": "The Effect of Pre-Operative Bacterial Decolonization on Post-Operative Infection Rate for Lower Extremity Wounds Healing by Second Intention",
"has_exemption": false,
"start_date": "2023-03-13",
"completion_date": "2030-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "The Cooper Health System",
"sponsor_slug": "the-cooper-health-system",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05933395",
"publication_url": "https://clinicaltrials.gov/study/NCT05933395",
"title": "Genetically-informed Therapy for ER+ Breast Cancer in a Post-CDK4/6 Inhibitor Setting: a Phase II Umbrella Study (GERTRUDE)",
"has_exemption": false,
"start_date": "2024-09-23",
"completion_date": "2030-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Dartmouth-Hitchcock Medical Center",
"sponsor_slug": "dartmouth-hitchcock-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06121180",
"publication_url": "https://clinicaltrials.gov/study/NCT06121180",
"title": "A Phase II Study of Cemiplimab Plus Ziv-Aflibercept for Subjects With Metastatic Uveal Melanoma",
"has_exemption": false,
"start_date": "2024-11-04",
"completion_date": "2030-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "H. Lee Moffitt Cancer Center and Research Institute",
"sponsor_slug": "h-lee-moffitt-cancer-center-and-research-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06628310",
"publication_url": "https://clinicaltrials.gov/study/NCT06628310",
"title": "A Phase 2 Randomized Study to Evaluate the Safety, Efficacy, and Optimal Dose of ABBV-400 in Combination With Fluorouracil, Leucovorin, and Budigalimab as First-Line Treatment in Subjects With Locally Advanced Unresectable or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma (AndroMETa-GEA-977)",
"has_exemption": false,
"start_date": "2024-12-13",
"completion_date": "2030-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "AbbVie",
"sponsor_slug": "abbvie",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06626516",
"publication_url": "https://clinicaltrials.gov/study/NCT06626516",
"title": "A Phase I/II Study of Tebentafusp-tebn in Combination With Liver-Directed Therapies for the Treatment of Metastatic Uveal Melanoma",
"has_exemption": false,
"start_date": "2025-10-15",
"completion_date": "2030-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Thomas Jefferson University",
"sponsor_slug": "thomas-jefferson-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07216248",
"publication_url": "https://clinicaltrials.gov/study/NCT07216248",
"title": "A Phase II Randomized, Decentralized, De-escalation Study in Patients With Metastatic Hormone-Sensitive Prostate Cancer Achieving Optimal PSA Response (OPTIMAS)",
"has_exemption": false,
"start_date": "2025-10-27",
"completion_date": "2030-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Utah",
"sponsor_slug": "university-of-utah",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07015190",
"publication_url": "https://clinicaltrials.gov/study/NCT07015190",
"title": "A Randomized, Phase 3, Open-label Study of Neoadjuvant Darovasertib in Subjects With Primary Non-metastatic Uveal Melanoma (OptimUM-10)",
"has_exemption": false,
"start_date": "2025-10-31",
"completion_date": "2030-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "IDEAYA Biosciences",
"sponsor_slug": "ideaya-biosciences",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07150715",
"publication_url": "https://clinicaltrials.gov/study/NCT07150715",
"title": "Alpha-Emitting Radionuclide or Beta-Emitting Radionuclide Combined With Metastasis-Directed Stereotactic Body Radiotherapy for Oligorecurrent Prostate Adenocarcinoma (ANDROMEDA)",
"has_exemption": false,
"start_date": "2025-10-31",
"completion_date": "2030-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Jonsson Comprehensive Cancer Center",
"sponsor_slug": "jonsson-comprehensive-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07148843",
"publication_url": "https://clinicaltrials.gov/study/NCT07148843",
"title": "Cannabidiol as an Adjunct Treatment for Alcohol Withdrawal and Craving",
"has_exemption": false,
"start_date": "2026-01-15",
"completion_date": "2030-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Johns Hopkins University",
"sponsor_slug": "johns-hopkins-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07043738",
"publication_url": "https://clinicaltrials.gov/study/NCT07043738",
"title": "Imaging- vs. Scalp-Targeted Accelerated TMS for Depression: The Number Needed to Scan Trial",
"has_exemption": false,
"start_date": "2026-01-31",
"completion_date": "2030-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Brigham and Women's Hospital",
"sponsor_slug": "brigham-and-womens-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03244072",
"publication_url": "https://clinicaltrials.gov/study/NCT03244072",
"title": "Safety and Efficacy of Intracameral Zimoxin (0.1% Moxifloxacin Solution) for Prevention of Endophthalmitis After Cataract Surgery",
"has_exemption": false,
"start_date": "2026-06-01",
"completion_date": "2030-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Jason Ahee, M.D.",
"sponsor_slug": "jason-ahee-md",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06458036",
"publication_url": "https://clinicaltrials.gov/study/NCT06458036",
"title": "Selpercatinib to Enhance RAI Avidity in Children, Adolescents, and Young Adults With Newly Diagnosed Differentiated Thyroid Cancers Harboring RET Fusions",
"has_exemption": false,
"start_date": "2024-07-29",
"completion_date": "2030-11-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Children's Hospital of Philadelphia",
"sponsor_slug": "childrens-hospital-of-philadelphia",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06541262",
"publication_url": "https://clinicaltrials.gov/study/NCT06541262",
"title": "Phase I/II Study of Silmitasertib (CX-4945) in Combination With Chemotherapy in Children and Young Adults With Relapsed Refractory Solid Tumors",
"has_exemption": false,
"start_date": "2024-10-30",
"completion_date": "2030-11-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Milton S. Hershey Medical Center",
"sponsor_slug": "milton-s-hershey-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06906887",
"publication_url": "https://clinicaltrials.gov/study/NCT06906887",
"title": "PULSO Trial: Pulsed Low-Dose-Rate (PLDR) Radiation Chemoradiation (CRT) vs. Standard CRT for Esophageal Cancer",
"has_exemption": false,
"start_date": "2025-06-17",
"completion_date": "2030-11-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Medical College of Wisconsin",
"sponsor_slug": "medical-college-of-wisconsin",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06934655",
"publication_url": "https://clinicaltrials.gov/study/NCT06934655",
"title": "Early Re-Initiation of Semaglutide Post Sleeve Gastrectomy in Youth",
"has_exemption": false,
"start_date": "2025-11-01",
"completion_date": "2030-11-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Children's Hospital Los Angeles",
"sponsor_slug": "childrens-hospital-los-angeles",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07136428",
"publication_url": "https://clinicaltrials.gov/study/NCT07136428",
"title": "A Single Arm, Open-label Phase Ib/II Study of Asciminib in HER2+ Breast Cancer Brain Metastases (ASCENdANT)",
"has_exemption": false,
"start_date": "2025-11-30",
"completion_date": "2030-11-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Duke University",
"sponsor_slug": "duke-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03750227",
"publication_url": "https://clinicaltrials.gov/study/NCT03750227",
"title": "Pre-Operative vs. Post-Operative Stereotactic Radiosurgery for Operative Metastatic Brain Tumors",
"has_exemption": false,
"start_date": "2018-11-19",
"completion_date": "2030-11-08",
"has_results": false,
"results_due": false,
"sponsor_name": "Mayo Clinic",
"sponsor_slug": "mayo-clinic",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07221149",
"publication_url": "https://clinicaltrials.gov/study/NCT07221149",
"title": "ROSETTA Gastric-204: A Blinded, Randomized, Phase 2/3 Study of Pumitamig in Combination With Chemotherapy Versus Nivolumab in Combination With Chemotherapy in Participants With Previously Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma",
"has_exemption": false,
"start_date": "2026-03-09",
"completion_date": "2030-11-08",
"has_results": false,
"results_due": false,
"sponsor_name": "Bristol-Myers Squibb",
"sponsor_slug": "bristol-myers-squibb",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07064460",
"publication_url": "https://clinicaltrials.gov/study/NCT07064460",
"title": "Duke Customized Aortic Aneurysm Repair With Endovascular Stent-grafts - Duke CARES Trial",
"has_exemption": false,
"start_date": "2025-11-11",
"completion_date": "2030-11-11",
"has_results": false,
"results_due": false,
"sponsor_name": "Chandler Long, MD",
"sponsor_slug": "chandler-long-md",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06995508",
"publication_url": "https://clinicaltrials.gov/study/NCT06995508",
"title": "Managing Anorexia During Chemoradiation With Olanzapine (MACRO)",
"has_exemption": false,
"start_date": "2025-11-15",
"completion_date": "2030-11-15",
"has_results": false,
"results_due": false,
"sponsor_name": "Roswell Park Cancer Institute",
"sponsor_slug": "roswell-park-cancer-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06052956",
"publication_url": "https://clinicaltrials.gov/study/NCT06052956",
"title": "A Phase 2 Study to Assess Efficacy of Methylene Blue Photodynamic Therapy for Treatment of Deep Tissue Abscesses",
"has_exemption": false,
"start_date": "2025-12-15",
"completion_date": "2030-11-15",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Rochester",
"sponsor_slug": "university-of-rochester",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07050186",
"publication_url": "https://clinicaltrials.gov/study/NCT07050186",
"title": "A Single Arm Open-Label Pilot Study to Investigate the Safety and Clinical Activity of Cemiplimab, A Fully Human Monoclonal Antibody to Programmed Death-1 (PD-1), in Patients With Incurable NUT Carcinoma (NC)",
"has_exemption": false,
"start_date": "2025-08-15",
"completion_date": "2030-11-20",
"has_results": false,
"results_due": false,
"sponsor_name": "Northwestern University",
"sponsor_slug": "northwestern-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05295290",
"publication_url": "https://clinicaltrials.gov/study/NCT05295290",
"title": "Low Interventional Cohort Study of Myocarditis/Pericarditis Associated With COMIRNATY in Persons Less Than 21 Years of Age",
"has_exemption": false,
"start_date": "2022-11-21",
"completion_date": "2030-11-21",
"has_results": false,
"results_due": false,
"sponsor_name": "Pfizer",
"sponsor_slug": "pfizer",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06128070",
"publication_url": "https://clinicaltrials.gov/study/NCT06128070",
"title": "Phase 2a Study of Adding Ruxolitinib With Tacrolimus/Methotrexate Regimen for Graft-versus-Host Disease Prophylaxis in Myeloablative Conditioning Hematopoietic Cell Transplantation in Pediatric and Young Adult Patients",
"has_exemption": false,
"start_date": "2024-07-16",
"completion_date": "2030-11-22",
"has_results": false,
"results_due": false,
"sponsor_name": "City of Hope Medical Center",
"sponsor_slug": "city-of-hope-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06211764",
"publication_url": "https://clinicaltrials.gov/study/NCT06211764",
"title": "A Phase 3, Randomized, Open-label, Multi-center Study Evaluating the Efficacy and Safety of TAR-200 Versus Investigator's Choice of Intravesical Chemotherapy in Participants Who Received Bacillus Calmette-Guérin (BCG) and Recurred With High-risk Non-muscle-invasive Bladder Cancer (HR-NMIBC) and Who Are Ineligible for or Elected Not to Undergo Radical Cystectomy",
"has_exemption": false,
"start_date": "2024-04-09",
"completion_date": "2030-11-27",
"has_results": false,
"results_due": false,
"sponsor_name": "Janssen Research & Development, LLC",
"sponsor_slug": "janssen-research-development-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07227597",
"publication_url": "https://clinicaltrials.gov/study/NCT07227597",
"title": "A Phase 1b/2 Open-label Study Evaluating Different MK-6070 and Ifinatamab Deruxtecan (MK-2400)-Based Regimens in First-line Extensive Stage Small Cell Lung Cancer",
"has_exemption": false,
"start_date": "2025-12-12",
"completion_date": "2030-11-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03587272",
"publication_url": "https://clinicaltrials.gov/study/NCT03587272",
"title": "Minimizing Toxicity in HLA-identical Sibling Donor Transplantation for Children With Sickle Cell Disease",
"has_exemption": false,
"start_date": "2018-04-17",
"completion_date": "2030-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Robert Nickel",
"sponsor_slug": "robert-nickel",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04157985",
"publication_url": "https://clinicaltrials.gov/study/NCT04157985",
"title": "Evaluating Length of Treatment With PD-1/PD-L1 Inhibitor in Advanced Solid Tumors",
"has_exemption": false,
"start_date": "2019-11-15",
"completion_date": "2030-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Dan Zandberg",
"sponsor_slug": "dan-zandberg",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04927416",
"publication_url": "https://clinicaltrials.gov/study/NCT04927416",
"title": "The Role of 68-Gallium-DOTATATE-PET/CT in the Imaging of Metastatic Thyroid Cancer",
"has_exemption": false,
"start_date": "2021-10-25",
"completion_date": "2030-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)",
"sponsor_slug": "national-institute-of-diabetes-and-digestive-and-kidney-diseases-niddk",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05967351",
"publication_url": "https://clinicaltrials.gov/study/NCT05967351",
"title": "A Phase 3, Multinational, Long-term Follow-up Study to Evaluate Safety and Efficacy in Subjects Who Have Previously Received SRP-9001 in a Clinical Study",
"has_exemption": false,
"start_date": "2023-09-27",
"completion_date": "2030-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Sarepta Therapeutics, Inc.",
"sponsor_slug": "sarepta-therapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06185673",
"publication_url": "https://clinicaltrials.gov/study/NCT06185673",
"title": "A Phase 1b/2a, Open-label, Dose Escalation Study to Evaluate the Safety and Clinical Activity of Intramuscular Doses of BB-301 Administered to Subjects With Oculopharyngeal Muscular Dystrophy With Dysphagia",
"has_exemption": false,
"start_date": "2023-11-28",
"completion_date": "2030-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Benitec Biopharma, Inc.",
"sponsor_slug": "benitec-biopharma-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06169371",
"publication_url": "https://clinicaltrials.gov/study/NCT06169371",
"title": "Abemaciclib Dose Escalation to Maintain Intensity (ADE-MI)",
"has_exemption": false,
"start_date": "2023-12-28",
"completion_date": "2030-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Illinois at Chicago",
"sponsor_slug": "university-of-illinois-at-chicago",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06462547",
"publication_url": "https://clinicaltrials.gov/study/NCT06462547",
"title": "The ADAPT Study: An Open-label, Long-term Safety Study of INZ-701 in Patients With ENPP1 Deficiency and ABCC6 Deficiency",
"has_exemption": false,
"start_date": "2024-06-19",
"completion_date": "2030-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Inozyme Pharma",
"sponsor_slug": "inozyme-pharma",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06608927",
"publication_url": "https://clinicaltrials.gov/study/NCT06608927",
"title": "A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase 3 Trial of Quemliclustat and Chemotherapy Versus Placebo and Chemotherapy in Patients With Treatment-Naive Metastatic Pancreatic Ductal Adenocarcinoma",
"has_exemption": false,
"start_date": "2024-12-13",
"completion_date": "2030-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Arcus Biosciences, Inc.",
"sponsor_slug": "arcus-biosciences-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06593093",
"publication_url": "https://clinicaltrials.gov/study/NCT06593093",
"title": "A Bundled Intervention to End Opioid Overdose by Increasing Treatment Uptake Post Emergency Department Discharge",
"has_exemption": false,
"start_date": "2025-02-13",
"completion_date": "2030-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Alabama at Birmingham",
"sponsor_slug": "university-of-alabama-at-birmingham",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06649357",
"publication_url": "https://clinicaltrials.gov/study/NCT06649357",
"title": "Comparison Between Bipolar Transurethral Resection of the Prostate and Moses Assisted Holmium Laser Enucleation of the Prostate. A Prospective Randomized Multicentric Study",
"has_exemption": false,
"start_date": "2025-04-01",
"completion_date": "2030-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Fundacio Puigvert",
"sponsor_slug": "fundacio-puigvert",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07223424",
"publication_url": "https://clinicaltrials.gov/study/NCT07223424",
"title": "Patient Preference for Subcutaneous vs. Intravenous Immune Therapy (PSI-Immune)",
"has_exemption": false,
"start_date": "2025-11-04",
"completion_date": "2030-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Diwakar Davar",
"sponsor_slug": "diwakar-davar",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07227636",
"publication_url": "https://clinicaltrials.gov/study/NCT07227636",
"title": "Phase II Study of Adjuvant Botensilimab in Combination With Balstilimab in Patients With Colorectal Cancer and Persistent Circulating Tumor DNA Following Surgery and Chemotherapy",
"has_exemption": false,
"start_date": "2025-11-07",
"completion_date": "2030-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Memorial Sloan Kettering Cancer Center",
"sponsor_slug": "memorial-sloan-kettering-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07220616",
"publication_url": "https://clinicaltrials.gov/study/NCT07220616",
"title": "A Phase 1/2, Multicenter, Open-Label, Multi-Cohort, First-in Human Trial of DS3790a, for Hematological Malignancies",
"has_exemption": false,
"start_date": "2025-11-12",
"completion_date": "2030-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Daiichi Sankyo",
"sponsor_slug": "daiichi-sankyo",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07172256",
"publication_url": "https://clinicaltrials.gov/study/NCT07172256",
"title": "A Pilot Study of CUE-101 in Combination With Pembrolizumab in Subjects With Newly Diagnosed, Locally Advanced HPV-16 Associated Head and Neck Cancer",
"has_exemption": false,
"start_date": "2025-11-30",
"completion_date": "2030-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Yale University",
"sponsor_slug": "yale-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07194590",
"publication_url": "https://clinicaltrials.gov/study/NCT07194590",
"title": "Equol Supplementation for Improving Vascular Function in Postmenopausal Women With CKD",
"has_exemption": false,
"start_date": "2025-12-01",
"completion_date": "2030-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Colorado, Denver",
"sponsor_slug": "university-of-colorado-denver",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05863351",
"publication_url": "https://clinicaltrials.gov/study/NCT05863351",
"title": "Phase III Randomized Trial of Stereotactic Ablative Radiotherapy (SAbR) for Oligometastatic Advanced Renal Carcinoma (SOAR)",
"has_exemption": false,
"start_date": "2023-09-07",
"completion_date": "2030-12-01",
"has_results": false,
"results_due": false,
"sponsor_name": "ECOG-ACRIN Cancer Research Group",
"sponsor_slug": "ecog-acrin-cancer-research-group",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06569680",
"publication_url": "https://clinicaltrials.gov/study/NCT06569680",
"title": "Phase II Trial of Mosunetuzumab in Patients With Newly Diagnosed Extranodal Marginal Zone Lymphoma (EMZL) (ML44933)",
"has_exemption": false,
"start_date": "2024-11-19",
"completion_date": "2030-12-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Izidore Lossos, MD",
"sponsor_slug": "izidore-lossos-md",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06540963",
"publication_url": "https://clinicaltrials.gov/study/NCT06540963",
"title": "Phase II Trial of Tipifarnib and Naxitamab for Relapsed/Refractory Neuroblastoma",
"has_exemption": false,
"start_date": "2024-12-06",
"completion_date": "2030-12-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Giselle Sholler",
"sponsor_slug": "giselle-sholler",
"status": "ongoing",
"is_pact": false,
"days_late": null
}
]
}